[
  {
    "questionId": "Screening_Criteria",
    "questionText": "Screening_Criteria",
    "items": [
      {
        "column": "Screening_Criteriar1",
        "label": "Screening_Criteriar1: I do not consent - Thank you for your interest in our survey. We know that this is a difficult time, especially for health care professionals. As such, we want you to know that we greatly appreciate you taking a break from all of the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-1",
        "rangeMin": 1,
        "rangeMax": 1,
        "allowedValues": [
          1
        ]
      }
    ]
  },
  {
    "questionId": "S5",
    "questionText": "S5",
    "items": [
      {
        "column": "S5r1",
        "label": "S5r1: For how many years have you practiced in this primary specialty, post-residency?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 4-30",
        "rangeMin": 4,
        "rangeMax": 30,
        "allowedValues": [
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30
        ]
      }
    ]
  },
  {
    "questionId": "S6",
    "questionText": "S6",
    "items": [
      {
        "column": "S6r1",
        "label": "S6r1: What percentage of your professional time is devoted to direct patient care / clinical practice as opposed to teaching, research or administration?",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 60-100",
        "rangeMin": 60,
        "rangeMax": 100
      }
    ]
  },
  {
    "questionId": "S7_H",
    "questionText": "S7_H",
    "items": [
      {
        "column": "S7_Hr1c1",
        "label": "S7_Hr1c1: Acute myeloid leukemia (AML) - In the past 12 months, how many patients were presented with the following oncologic conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your p",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-376",
        "rangeMin": 0,
        "rangeMax": 376
      },
      {
        "column": "S7_Hr2c1",
        "label": "S7_Hr2c1: Acute lymphoblastic leukemia (ALL) - In the past 12 months, how many patients were presented with the following oncologic conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-520",
        "rangeMin": 0,
        "rangeMax": 520
      },
      {
        "column": "S7_Hr3c1",
        "label": "S7_Hr3c1: Prostate cancer - In the past 12 months, how many patients were presented with the following oncologic conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and n",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-400",
        "rangeMin": 0,
        "rangeMax": 400
      },
      {
        "column": "S7_Hr4c1",
        "label": "S7_Hr4c1: Multiple myeloma - In the past 12 months, how many patients were presented with the following oncologic conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-390",
        "rangeMin": 10,
        "rangeMax": 390
      },
      {
        "column": "S7_Hr5c1",
        "label": "S7_Hr5c1: Chronic lymphocytic leukemia (CLL) - In the past 12 months, how many patients were presented with the following oncologic conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-400",
        "rangeMin": 10,
        "rangeMax": 400
      },
      {
        "column": "S7_Hr6c1",
        "label": "S7_Hr6c1: Bladder cancer - In the past 12 months, how many patients were presented with the following oncologic conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and no",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-450",
        "rangeMin": 0,
        "rangeMax": 450
      }
    ]
  },
  {
    "questionId": "S7a_H",
    "questionText": "S7a_H",
    "items": [
      {
        "column": "S7a_Hr1c1",
        "label": "S7a_Hr1c1: Acute myeloid leukemia (AML) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have see",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-230",
        "rangeMin": 0,
        "rangeMax": 230
      },
      {
        "column": "S7a_Hr2c1",
        "label": "S7a_Hr2c1: Acute lymphoblastic leukemia (ALL) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you ha",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-250",
        "rangeMin": 0,
        "rangeMax": 250
      },
      {
        "column": "S7a_Hr3c1",
        "label": "S7a_Hr3c1: Prostate cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least on",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-210",
        "rangeMin": 0,
        "rangeMax": 210
      },
      {
        "column": "S7a_Hr4c1",
        "label": "S7a_Hr4c1: Multiple myeloma - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least o",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-230",
        "rangeMin": 10,
        "rangeMax": 230
      },
      {
        "column": "S7a_Hr5c1",
        "label": "S7a_Hr5c1: Chronic lymphocytic leukemia (CLL) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you ha",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-200",
        "rangeMin": 10,
        "rangeMax": 200
      },
      {
        "column": "S7a_Hr6c1",
        "label": "S7a_Hr6c1: Bladder cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncologic conditions? For “actively managed” please refer to patients you have seen at least onc",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-221",
        "rangeMin": 0,
        "rangeMax": 221
      }
    ]
  },
  {
    "questionId": "S7_O",
    "questionText": "S7_O",
    "items": [
      {
        "column": "S7_Or1c1",
        "label": "S7_Or1c1: Prostate cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and no",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-310",
        "rangeMin": 10,
        "rangeMax": 310
      },
      {
        "column": "S7_Or2c1",
        "label": "S7_Or2c1: Acute myeloid leukemia (AML) - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your pr",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-240",
        "rangeMin": 0,
        "rangeMax": 240
      },
      {
        "column": "S7_Or3c1",
        "label": "S7_Or3c1: Acute lymphoblastic leukemia (ALL) - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in y",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-185",
        "rangeMin": 0,
        "rangeMax": 185
      },
      {
        "column": "S7_Or4c1",
        "label": "S7_Or4c1: Breast cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-400",
        "rangeMin": 0,
        "rangeMax": 400
      },
      {
        "column": "S7_Or5c1",
        "label": "S7_Or5c1: Colorectal cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-390",
        "rangeMin": 0,
        "rangeMax": 390
      },
      {
        "column": "S7_Or6c1",
        "label": "S7_Or6c1: Bladder cancer - In the past 12 months, how many patients were presented with the following oncology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-210",
        "rangeMin": 0,
        "rangeMax": 210
      }
    ]
  },
  {
    "questionId": "S7a_O",
    "questionText": "S7a_O",
    "items": [
      {
        "column": "S7a_Or1c1",
        "label": "S7a_Or1c1: Prostate cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least onc",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-310",
        "rangeMin": 10,
        "rangeMax": 310
      },
      {
        "column": "S7a_Or2c1",
        "label": "S7a_Or2c1: Acute myeloid leukemia (AML) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-180",
        "rangeMin": 0,
        "rangeMax": 180
      },
      {
        "column": "S7a_Or3c1",
        "label": "S7a_Or3c1: Acute lymphoblastic leukemia (ALL) - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you hav",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-130",
        "rangeMin": 0,
        "rangeMax": 130
      },
      {
        "column": "S7a_Or4c1",
        "label": "S7a_Or4c1: Breast cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least once",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-400",
        "rangeMin": 0,
        "rangeMax": 400
      },
      {
        "column": "S7a_Or5c1",
        "label": "S7a_Or5c1: Colorectal cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least o",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-380",
        "rangeMin": 0,
        "rangeMax": 380
      },
      {
        "column": "S7a_Or6c1",
        "label": "S7a_Or6c1: Bladder cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following oncology conditions? For “actively managed” please refer to patients you have seen at least once",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-200",
        "rangeMin": 0,
        "rangeMax": 200
      }
    ]
  },
  {
    "questionId": "S7_U",
    "questionText": "S7_U",
    "items": [
      {
        "column": "S7_Ur1c1",
        "label": "S7_Ur1c1: Prostate cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 35-999",
        "rangeMin": 35,
        "rangeMax": 999
      },
      {
        "column": "S7_Ur2c1",
        "label": "S7_Ur2c1: Bladder cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-900",
        "rangeMin": 10,
        "rangeMax": 900
      },
      {
        "column": "S7_Ur3c1",
        "label": "S7_Ur3c1: Testicular cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and n",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-111",
        "rangeMin": 0,
        "rangeMax": 111
      },
      {
        "column": "S7_Ur4c1",
        "label": "S7_Ur4c1: Kidney cancer - In the past 12 months, how many patients were presented with the following urology conditions in your practice? Please consider all patients who came to your practice including those who were: diagnosed in your practice and not t",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-600",
        "rangeMin": 0,
        "rangeMax": 600
      }
    ]
  },
  {
    "questionId": "S7a_U",
    "questionText": "S7a_U",
    "items": [
      {
        "column": "S7a_Ur1c1",
        "label": "S7a_Ur1c1: Prostate cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 20-999",
        "rangeMin": 20,
        "rangeMax": 999
      },
      {
        "column": "S7a_Ur2c1",
        "label": "S7a_Ur2c1: Bladder cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 10-900",
        "rangeMin": 10,
        "rangeMax": 900
      },
      {
        "column": "S7a_Ur3c1",
        "label": "S7a_Ur3c1: Testicular cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least on",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-111",
        "rangeMin": 0,
        "rangeMax": 111
      },
      {
        "column": "S7a_Ur4c1",
        "label": "S7a_Ur4c1: Kidney cancer - Of all those patients, in the past 12 months, how many unique patients have you personally actively managed with the following urology conditions? For “actively managed” please refer to patients you have seen at least once i",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-600",
        "rangeMin": 0,
        "rangeMax": 600
      }
    ]
  },
  {
    "questionId": "S7_B",
    "questionText": "S7_B",
    "items": [
      {
        "column": "S7_Br1",
        "label": "S7_Br1: Of your [pipe: S7_B_Pipe] prostate cancer patients, how many were actively managed for non-curative prostate cancer in the past 12 months? Non-curative prostate cancer patients are those that have progressed after receiving definitive therapy (e.g",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 4-400",
        "rangeMin": 4,
        "rangeMax": 400
      }
    ]
  },
  {
    "questionId": "S7_C",
    "questionText": "S7_C",
    "items": [
      {
        "column": "S7_Cr1",
        "label": "S7_Cr1: Of your [pipe: S7_C_Pipe] bladder cancer patients actively managed in the past 12 months, how many were locally advanced or metastatic? Include patients you treat currently AND patients you referred to clinical trial in the last 12 months AND your",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-200",
        "rangeMin": 1,
        "rangeMax": 200
      }
    ]
  },
  {
    "questionId": "S8",
    "questionText": "S8",
    "items": [
      {
        "column": "S8r1",
        "label": "S8r1: General Practice - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S8r2",
        "label": "S8r2: Hematology - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S8r3",
        "label": "S8r3: Hematology-Oncology - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S8r4",
        "label": "S8r4: Medical Oncology - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S8r5",
        "label": "S8r5: Gastroenterology - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S8r6",
        "label": "S8r6: Urology - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S8r7",
        "label": "S8r7: Cardiology - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S8r8",
        "label": "S8r8: Other (please specify:) - [pipe: S8_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "S9",
    "questionText": "S9",
    "items": [
      {
        "column": "S9r1c1",
        "label": "S9r1c1: General Practice - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 2-200",
        "rangeMin": 2,
        "rangeMax": 200
      },
      {
        "column": "S9r2c1",
        "label": "S9r2c1: Hematologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-40",
        "rangeMin": 1,
        "rangeMax": 40,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30,
          31,
          32,
          33,
          34,
          35,
          36,
          37,
          38,
          39,
          40
        ]
      },
      {
        "column": "S9r3c1",
        "label": "S9r3c1: Hematologist-Oncologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-80",
        "rangeMin": 1,
        "rangeMax": 80
      },
      {
        "column": "S9r4c1",
        "label": "S9r4c1: Medical Oncologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-90",
        "rangeMin": 1,
        "rangeMax": 90
      },
      {
        "column": "S9r5c1",
        "label": "S9r5c1: Gastroenterologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-35",
        "rangeMin": 1,
        "rangeMax": 35,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30,
          31,
          32,
          33,
          34,
          35
        ]
      },
      {
        "column": "S9r6c1",
        "label": "S9r6c1: Urologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-70",
        "rangeMin": 1,
        "rangeMax": 70
      },
      {
        "column": "S9r7c1",
        "label": "S9r7c1: Cardiologist - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-50",
        "rangeMin": 1,
        "rangeMax": 50,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30,
          31,
          32,
          33,
          34,
          35,
          36,
          37,
          38,
          39,
          40,
          41,
          42,
          43,
          44,
          45,
          46,
          47,
          48,
          49,
          50
        ]
      },
      {
        "column": "S9r8c1",
        "label": "S9r8c1: $ {S8.r8.open} - [pipe: S9_QText] If your practice has multiple locations, please consider your primary location.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 2-40",
        "rangeMin": 2,
        "rangeMax": 40,
        "allowedValues": [
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30,
          31,
          32,
          33,
          34,
          35,
          36,
          37,
          38,
          39,
          40
        ]
      }
    ]
  },
  {
    "questionId": "S9a",
    "questionText": "S9a",
    "items": [
      {
        "column": "S9ar1",
        "label": "S9ar1: General Practice - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9ar2",
        "label": "S9ar2: Hematology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9ar3",
        "label": "S9ar3: Hematology-Oncology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9ar4",
        "label": "S9ar4: Medical Oncology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9ar5",
        "label": "S9ar5: Gastroenterology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9ar6",
        "label": "S9ar6: Urology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9ar7",
        "label": "S9ar7: Cardiology - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9ar8",
        "label": "S9ar8: $ {S8.r8.open} - What is the primary medical specialty of the physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "S10",
    "questionText": "S10",
    "items": [
      {
        "column": "S10r1",
        "label": "S10r1: Acute myeloid leukemia (AML) - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r2",
        "label": "S10r2: Prostate cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r3",
        "label": "S10r3: Acute lymphoblastic leukemia (ALL) - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r4",
        "label": "S10r4: Breast cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r5",
        "label": "S10r5: Colorectal cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r6",
        "label": "S10r6: Multiple myeloma - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r7",
        "label": "S10r7: Chronic lymphocytic leukemia (CLL) - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r8",
        "label": "S10r8: Bladder cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r9",
        "label": "S10r9: Testicular cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r10",
        "label": "S10r10: Kidney cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r11",
        "label": "S10r11: Other (please specify:) - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S10r12",
        "label": "S10r12: None, physicians I work with directly do not commonly treat cancer - Which types of cancer are commonly treated by physicians with whom you yourself work directly?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "S11",
    "questionText": "S11",
    "items": [
      {
        "column": "S11r1",
        "label": "S11r1: Manage initiation kits/bridge programs (free drug for new starts while benefits are being verified or getting approval for coverage) - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer dru",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r2",
        "label": "S11r2: Enroll patients in patient assistance/free drug programs - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r3",
        "label": "S11r3: Coordinate with specialty pharmacies to get patients access to medications - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r4",
        "label": "S11r4: Call manufacturer-sponsored reimbursement assistance hotlines - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r5",
        "label": "S11r5: Analyze and work with patients on coverage verification and patient out-of-pocket responsibility amounts - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r6",
        "label": "S11r6: Work with drug companies to negotiate contracts and/or billing terms - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r7",
        "label": "S11r7: Coordinate with drug companies to ensure supplies of samples, address issues with expired drugs, etc. - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r8",
        "label": "S11r8: Work with physicians and insurance companies to obtain prior authorizations - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S11r9",
        "label": "S11r9: I do not routinely perform any of the tasks above - In which of the following ways do you, yourself, interface with pharmaceutical manufacturers regarding cancer drugs?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "S12",
    "questionText": "S12",
    "items": [
      {
        "column": "S12r1",
        "label": "S12r1: Astellas - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r2",
        "label": "S12r2: Merck / EMD Serono - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conv",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r3",
        "label": "S12r3: Bristol-Myers Squibb (BMS) - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussi",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r4",
        "label": "S12r4: Genentech / Roche - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conve",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r5",
        "label": "S12r5: Pfizer - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r6",
        "label": "S12r6: Janssen / Johnson & Johnson - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discuss",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r7",
        "label": "S12r7: Bayer - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r8",
        "label": "S12r8: Abbvie - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r9",
        "label": "S12r9: Sanofi - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r10",
        "label": "S12r10: Lilly - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r11",
        "label": "S12r11: Novartis - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r12",
        "label": "S12r12: Daiichi-Sankyo - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, convers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r13",
        "label": "S12r13: Amgen - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r14",
        "label": "S12r14: Seattle Genetics - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conve",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r15",
        "label": "S12r15: GSK - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversation at a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r16",
        "label": "S12r16: AstraZeneca - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion, conversati",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      },
      {
        "column": "S12r17",
        "label": "S12r17: Gilead / Immunomedics - In the past 6 months, please indicate whether you have interacted with each of the following companies related to their oncology drugs. This could include any type of interaction such as an in-person or virtual discussion,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S12a",
    "questionText": "S12a",
    "items": [
      {
        "column": "S12ar1",
        "label": "S12ar1: Astellas - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar2",
        "label": "S12ar2: Merck / EMD Serono - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar3",
        "label": "S12ar3: Bristol-Myers Squibb (BMS) - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar4",
        "label": "S12ar4: Genentech / Roche - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar5",
        "label": "S12ar5: Pfizer - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar6",
        "label": "S12ar6: Janssen / Johnson & Johnson - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar7",
        "label": "S12ar7: Bayer - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar8",
        "label": "S12ar8: Abbvie - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar9",
        "label": "S12ar9: Sanofi - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar10",
        "label": "S12ar10: Lilly - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar11",
        "label": "S12ar11: Novartis - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar12",
        "label": "S12ar12: Daiichi-Sankyo - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar13",
        "label": "S12ar13: Amgen - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar14",
        "label": "S12ar14: Seattle Genetics - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar15",
        "label": "S12ar15: GSK - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar16",
        "label": "S12ar16: AstraZeneca - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar17",
        "label": "S12ar17: Gilead / Immunomedics - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12ar18",
        "label": "S12ar18: None of the above - Please indicate which of the following companies, if any, you are aware of that manufacture and promote oncology drugs.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "S12_LF",
    "questionText": "S12_LF",
    "items": [
      {
        "column": "S12_LFr1",
        "label": "S12_LFr1: Astellas - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr2",
        "label": "S12_LFr2: Merck / EMD Serono - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr3",
        "label": "S12_LFr3: Bristol-Myers Squibb (BMS) - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr4",
        "label": "S12_LFr4: Genentech / Roche - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr5",
        "label": "S12_LFr5: Pfizer - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr6",
        "label": "S12_LFr6: Janssen / Johnson & Johnson - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr7",
        "label": "S12_LFr7: Bayer - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr8",
        "label": "S12_LFr8: Abbvie - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr9",
        "label": "S12_LFr9: Sanofi - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr10",
        "label": "S12_LFr10: Lilly - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr11",
        "label": "S12_LFr11: Novartis - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr12",
        "label": "S12_LFr12: Daiichi-Sankyo - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr13",
        "label": "S12_LFr13: Amgen - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr14",
        "label": "S12_LFr14: Seattle Genetics - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr15",
        "label": "S12_LFr15: GSK - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr16",
        "label": "S12_LFr16: AstraZeneca - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S12_LFr17",
        "label": "S12_LFr17: Gilead / Immunomedics - Listfill for S12",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q1",
    "questionText": "Q1",
    "items": [
      {
        "column": "Q1r1c1",
        "label": "Q1r1c1: Astellas - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Pl",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-65",
        "rangeMin": 1,
        "rangeMax": 65
      },
      {
        "column": "Q1r1c2",
        "label": "Q1r1c2: Merck / EMD Serono - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-20",
        "rangeMin": 1,
        "rangeMax": 20,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20
        ]
      },
      {
        "column": "Q1r1c3",
        "label": "Q1r1c3: Bristol-Myers Squibb (BMS) - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in th",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-1",
        "rangeMin": 1,
        "rangeMax": 1,
        "allowedValues": [
          1
        ]
      },
      {
        "column": "Q1r1c4",
        "label": "Q1r1c4: Genentech / Roche - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-30",
        "rangeMin": 1,
        "rangeMax": 30,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30
        ]
      },
      {
        "column": "Q1r1c5",
        "label": "Q1r1c5: Pfizer - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-30",
        "rangeMin": 1,
        "rangeMax": 30,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30
        ]
      },
      {
        "column": "Q1r1c6",
        "label": "Q1r1c6: Janssen / Johnson & Johnson - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in t",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-20",
        "rangeMin": 1,
        "rangeMax": 20,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20
        ]
      },
      {
        "column": "Q1r1c7",
        "label": "Q1r1c7: Bayer - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Pleas",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-40",
        "rangeMin": 1,
        "rangeMax": 40,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30,
          31,
          32,
          33,
          34,
          35,
          36,
          37,
          38,
          39,
          40
        ]
      },
      {
        "column": "Q1r1c8",
        "label": "Q1r1c8: Abbvie - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-70",
        "rangeMin": 1,
        "rangeMax": 70
      },
      {
        "column": "Q1r1c9",
        "label": "Q1r1c9: Sanofi - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: [object Object]-[object Object]",
        "rangeMin": {},
        "rangeMax": {}
      },
      {
        "column": "Q1r1c10",
        "label": "Q1r1c10: Lilly - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: [object Object]-[object Object]",
        "rangeMin": {},
        "rangeMax": {}
      },
      {
        "column": "Q1r1c11",
        "label": "Q1r1c11: Novartis - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?P",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-80",
        "rangeMin": 1,
        "rangeMax": 80
      },
      {
        "column": "Q1r1c12",
        "label": "Q1r1c12: Daiichi-Sankyo - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 mo",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-1",
        "rangeMin": 1,
        "rangeMax": 1,
        "allowedValues": [
          1
        ]
      },
      {
        "column": "Q1r1c13",
        "label": "Q1r1c13: Amgen - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Plea",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ]
      },
      {
        "column": "Q1r1c14",
        "label": "Q1r1c14: Seattle Genetics - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1-65",
        "rangeMin": 1,
        "rangeMax": 65
      },
      {
        "column": "Q1r1c15",
        "label": "Q1r1c15: GSK - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 months?Please",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-1",
        "rangeMin": 1,
        "rangeMax": 1,
        "allowedValues": [
          1
        ]
      },
      {
        "column": "Q1r1c16",
        "label": "Q1r1c16: AstraZeneca - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the past 6 month",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 2-4",
        "rangeMin": 2,
        "rangeMax": 4,
        "allowedValues": [
          2,
          3,
          4
        ]
      },
      {
        "column": "Q1r1c17",
        "label": "Q1r1c17: Gilead / Immunomedics - You indicated that you have interacted with the following companies in the past 6 months: . For each of these companies, approximately how many times have you interacted with the company related to oncology drugs in the pa",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-20",
        "rangeMin": 1,
        "rangeMax": 20,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20
        ]
      }
    ]
  },
  {
    "questionId": "Q2",
    "questionText": "Q2",
    "items": [
      {
        "column": "Q2c1",
        "label": "Q2c1: Astellas - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c2",
        "label": "Q2c2: Merck / EMD Serono - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c3",
        "label": "Q2c3: Bristol-Myers Squibb (BMS) - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c4",
        "label": "Q2c4: Genentech / Roche - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c5",
        "label": "Q2c5: Pfizer - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c6",
        "label": "Q2c6: Janssen / Johnson & Johnson - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c7",
        "label": "Q2c7: Bayer - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c8",
        "label": "Q2c8: Abbvie - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c9",
        "label": "Q2c9: Sanofi - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c10",
        "label": "Q2c10: Lilly - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c11",
        "label": "Q2c11: Novartis - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c12",
        "label": "Q2c12: Daiichi-Sankyo - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c13",
        "label": "Q2c13: Amgen - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c14",
        "label": "Q2c14: Seattle Genetics - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c15",
        "label": "Q2c15: GSK - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c16",
        "label": "Q2c16: AstraZeneca - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      },
      {
        "column": "Q2c17",
        "label": "Q2c17: Gilead / Immunomedics - For each company, please indicate when, to the best of your recollection, you had your MOST RECENT interaction:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Within the past week"
          },
          {
            "value": 2,
            "label": "2-3 weeks ago"
          },
          {
            "value": 3,
            "label": "1-3 months ago"
          },
          {
            "value": 4,
            "label": "Between 3 and 6 months ago"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q3",
    "questionText": "Q3",
    "items": [
      {
        "column": "Q3r1c1",
        "label": "Q3r1c1: In person discussion (i.e. at practice setting) - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c1",
        "label": "Q3r8c1: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c1",
        "label": "Q3r2c1: Telephone call - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c1",
        "label": "Q3r3c1: Email communication - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c1",
        "label": "Q3r4c1: Conference discussion (e.g. virtual or live booth visit, meeting) - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c1",
        "label": "Q3r5c1: Website / Online portal - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c1",
        "label": "Q3r6c1: Other type of interaction, Specify: - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c1",
        "label": "Q3r7c1: Other type of interaction, Specify: - Astellas - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c2",
        "label": "Q3r1c2: In person discussion (i.e. at practice setting) - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c2",
        "label": "Q3r8c2: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c2",
        "label": "Q3r2c2: Telephone call - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c2",
        "label": "Q3r3c2: Email communication - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c2",
        "label": "Q3r4c2: Conference discussion (e.g. virtual or live booth visit, meeting) - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c2",
        "label": "Q3r5c2: Website / Online portal - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c2",
        "label": "Q3r6c2: Other type of interaction, Specify: - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c2",
        "label": "Q3r7c2: Other type of interaction, Specify: - Merck / EMD Serono - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c3",
        "label": "Q3r1c3: In person discussion (i.e. at practice setting) - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c3",
        "label": "Q3r8c3: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c3",
        "label": "Q3r2c3: Telephone call - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c3",
        "label": "Q3r3c3: Email communication - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c3",
        "label": "Q3r4c3: Conference discussion (e.g. virtual or live booth visit, meeting) - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c3",
        "label": "Q3r5c3: Website / Online portal - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c3",
        "label": "Q3r6c3: Other type of interaction, Specify: - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c3",
        "label": "Q3r7c3: Other type of interaction, Specify: - Bristol-Myers Squibb (BMS) - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c4",
        "label": "Q3r1c4: In person discussion (i.e. at practice setting) - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c4",
        "label": "Q3r8c4: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c4",
        "label": "Q3r2c4: Telephone call - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c4",
        "label": "Q3r3c4: Email communication - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c4",
        "label": "Q3r4c4: Conference discussion (e.g. virtual or live booth visit, meeting) - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c4",
        "label": "Q3r5c4: Website / Online portal - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c4",
        "label": "Q3r6c4: Other type of interaction, Specify: - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c4",
        "label": "Q3r7c4: Other type of interaction, Specify: - Genentech / Roche - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c5",
        "label": "Q3r1c5: In person discussion (i.e. at practice setting) - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c5",
        "label": "Q3r8c5: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c5",
        "label": "Q3r2c5: Telephone call - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c5",
        "label": "Q3r3c5: Email communication - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c5",
        "label": "Q3r4c5: Conference discussion (e.g. virtual or live booth visit, meeting) - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c5",
        "label": "Q3r5c5: Website / Online portal - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c5",
        "label": "Q3r6c5: Other type of interaction, Specify: - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c5",
        "label": "Q3r7c5: Other type of interaction, Specify: - Pfizer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c6",
        "label": "Q3r1c6: In person discussion (i.e. at practice setting) - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c6",
        "label": "Q3r8c6: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c6",
        "label": "Q3r2c6: Telephone call - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c6",
        "label": "Q3r3c6: Email communication - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c6",
        "label": "Q3r4c6: Conference discussion (e.g. virtual or live booth visit, meeting) - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 month",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c6",
        "label": "Q3r5c6: Website / Online portal - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c6",
        "label": "Q3r6c6: Other type of interaction, Specify: - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c6",
        "label": "Q3r7c6: Other type of interaction, Specify: - Janssen / Johnson & Johnson - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c7",
        "label": "Q3r1c7: In person discussion (i.e. at practice setting) - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c7",
        "label": "Q3r8c7: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c7",
        "label": "Q3r2c7: Telephone call - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c7",
        "label": "Q3r3c7: Email communication - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c7",
        "label": "Q3r4c7: Conference discussion (e.g. virtual or live booth visit, meeting) - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c7",
        "label": "Q3r5c7: Website / Online portal - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c7",
        "label": "Q3r6c7: Other type of interaction, Specify: - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c7",
        "label": "Q3r7c7: Other type of interaction, Specify: - Bayer - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c8",
        "label": "Q3r1c8: In person discussion (i.e. at practice setting) - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c8",
        "label": "Q3r8c8: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c8",
        "label": "Q3r2c8: Telephone call - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c8",
        "label": "Q3r3c8: Email communication - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c8",
        "label": "Q3r4c8: Conference discussion (e.g. virtual or live booth visit, meeting) - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c8",
        "label": "Q3r5c8: Website / Online portal - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c8",
        "label": "Q3r6c8: Other type of interaction, Specify: - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c8",
        "label": "Q3r7c8: Other type of interaction, Specify: - Abbvie - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c9",
        "label": "Q3r1c9: In person discussion (i.e. at practice setting) - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c9",
        "label": "Q3r8c9: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c9",
        "label": "Q3r2c9: Telephone call - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c9",
        "label": "Q3r3c9: Email communication - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c9",
        "label": "Q3r4c9: Conference discussion (e.g. virtual or live booth visit, meeting) - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c9",
        "label": "Q3r5c9: Website / Online portal - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c9",
        "label": "Q3r6c9: Other type of interaction, Specify: - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c9",
        "label": "Q3r7c9: Other type of interaction, Specify: - Sanofi - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c10",
        "label": "Q3r1c10: In person discussion (i.e. at practice setting) - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c10",
        "label": "Q3r8c10: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c10",
        "label": "Q3r2c10: Telephone call - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c10",
        "label": "Q3r3c10: Email communication - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c10",
        "label": "Q3r4c10: Conference discussion (e.g. virtual or live booth visit, meeting) - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c10",
        "label": "Q3r5c10: Website / Online portal - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c10",
        "label": "Q3r6c10: Other type of interaction, Specify: - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c10",
        "label": "Q3r7c10: Other type of interaction, Specify: - Lilly - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c11",
        "label": "Q3r1c11: In person discussion (i.e. at practice setting) - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c11",
        "label": "Q3r8c11: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c11",
        "label": "Q3r2c11: Telephone call - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c11",
        "label": "Q3r3c11: Email communication - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c11",
        "label": "Q3r4c11: Conference discussion (e.g. virtual or live booth visit, meeting) - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c11",
        "label": "Q3r5c11: Website / Online portal - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c11",
        "label": "Q3r6c11: Other type of interaction, Specify: - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c11",
        "label": "Q3r7c11: Other type of interaction, Specify: - Novartis - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c12",
        "label": "Q3r1c12: In person discussion (i.e. at practice setting) - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c12",
        "label": "Q3r8c12: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c12",
        "label": "Q3r2c12: Telephone call - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c12",
        "label": "Q3r3c12: Email communication - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c12",
        "label": "Q3r4c12: Conference discussion (e.g. virtual or live booth visit, meeting) - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c12",
        "label": "Q3r5c12: Website / Online portal - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c12",
        "label": "Q3r6c12: Other type of interaction, Specify: - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c12",
        "label": "Q3r7c12: Other type of interaction, Specify: - Daiichi-Sankyo - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c13",
        "label": "Q3r1c13: In person discussion (i.e. at practice setting) - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c13",
        "label": "Q3r8c13: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c13",
        "label": "Q3r2c13: Telephone call - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c13",
        "label": "Q3r3c13: Email communication - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c13",
        "label": "Q3r4c13: Conference discussion (e.g. virtual or live booth visit, meeting) - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c13",
        "label": "Q3r5c13: Website / Online portal - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c13",
        "label": "Q3r6c13: Other type of interaction, Specify: - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c13",
        "label": "Q3r7c13: Other type of interaction, Specify: - Amgen - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c14",
        "label": "Q3r1c14: In person discussion (i.e. at practice setting) - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c14",
        "label": "Q3r8c14: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c14",
        "label": "Q3r2c14: Telephone call - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c14",
        "label": "Q3r3c14: Email communication - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c14",
        "label": "Q3r4c14: Conference discussion (e.g. virtual or live booth visit, meeting) - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c14",
        "label": "Q3r5c14: Website / Online portal - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c14",
        "label": "Q3r6c14: Other type of interaction, Specify: - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c14",
        "label": "Q3r7c14: Other type of interaction, Specify: - Seattle Genetics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c15",
        "label": "Q3r1c15: In person discussion (i.e. at practice setting) - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c15",
        "label": "Q3r8c15: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c15",
        "label": "Q3r2c15: Telephone call - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c15",
        "label": "Q3r3c15: Email communication - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c15",
        "label": "Q3r4c15: Conference discussion (e.g. virtual or live booth visit, meeting) - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c15",
        "label": "Q3r5c15: Website / Online portal - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c15",
        "label": "Q3r6c15: Other type of interaction, Specify: - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c15",
        "label": "Q3r7c15: Other type of interaction, Specify: - GSK - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c16",
        "label": "Q3r1c16: In person discussion (i.e. at practice setting) - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c16",
        "label": "Q3r8c16: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c16",
        "label": "Q3r2c16: Telephone call - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c16",
        "label": "Q3r3c16: Email communication - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c16",
        "label": "Q3r4c16: Conference discussion (e.g. virtual or live booth visit, meeting) - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c16",
        "label": "Q3r5c16: Website / Online portal - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c16",
        "label": "Q3r6c16: Other type of interaction, Specify: - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c16",
        "label": "Q3r7c16: Other type of interaction, Specify: - AstraZeneca - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r1c17",
        "label": "Q3r1c17: In person discussion (i.e. at practice setting) - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r8c17",
        "label": "Q3r8c17: Virtual discussion (e.g. Zoom, Teams, Skype, Veeva Engage) - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r2c17",
        "label": "Q3r2c17: Telephone call - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r3c17",
        "label": "Q3r3c17: Email communication - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r4c17",
        "label": "Q3r4c17: Conference discussion (e.g. virtual or live booth visit, meeting) - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r5c17",
        "label": "Q3r5c17: Website / Online portal - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r6c17",
        "label": "Q3r6c17: Other type of interaction, Specify: - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3r7c17",
        "label": "Q3r7c17: Other type of interaction, Specify: - Gilead / Immunomedics - For each of these companies, please indicate all the types of interactions you have had with them related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q3a",
    "questionText": "Q3a",
    "items": [
      {
        "column": "Q3ar1c1",
        "label": "Q3ar1c1: Product sales representative - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c1",
        "label": "Q3ar2c1: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inter",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c1",
        "label": "Q3ar8c1: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Astellas - For each of these companies, to the best of your ability, please ind",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c1",
        "label": "Q3ar9c1: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inter",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c1",
        "label": "Q3ar3c1: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interact",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c1",
        "label": "Q3ar7c1: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology d",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c1",
        "label": "Q3ar4c1: Other type of person (Specify): - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c1",
        "label": "Q3ar5c1: Other type of person (Specify): - Astellas - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c2",
        "label": "Q3ar1c2: Product sales representative - Merck / EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c2",
        "label": "Q3ar2c2: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Merck / EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c2",
        "label": "Q3ar8c2: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Merck / EMD Serono - For each of these companies, to the best of your ability,",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c2",
        "label": "Q3ar9c2: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Merck / EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c2",
        "label": "Q3ar3c2: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Merck / EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you hav",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c2",
        "label": "Q3ar7c2: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Merck / EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c2",
        "label": "Q3ar4c2: Other type of person (Specify): - Merck / EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c2",
        "label": "Q3ar5c2: Other type of person (Specify): - Merck / EMD Serono - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c3",
        "label": "Q3ar1c3: Product sales representative - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c3",
        "label": "Q3ar2c3: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of person",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c3",
        "label": "Q3ar8c3: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your a",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c3",
        "label": "Q3ar9c3: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of person",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c3",
        "label": "Q3ar3c3: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c3",
        "label": "Q3ar7c3: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related t",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c3",
        "label": "Q3ar4c3: Other type of person (Specify): - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c3",
        "label": "Q3ar5c3: Other type of person (Specify): - Bristol-Myers Squibb (BMS) - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c4",
        "label": "Q3ar1c4: Product sales representative - Genentech / Roche - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c4",
        "label": "Q3ar2c4: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Genentech / Roche - For each of these companies, to the best of your ability, please indicate all the types of personnel you h",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c4",
        "label": "Q3ar8c4: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Genentech / Roche - For each of these companies, to the best of your ability, p",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c4",
        "label": "Q3ar9c4: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Genentech / Roche - For each of these companies, to the best of your ability, please indicate all the types of personnel you h",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c4",
        "label": "Q3ar3c4: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Genentech / Roche - For each of these companies, to the best of your ability, please indicate all the types of personnel you have",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c4",
        "label": "Q3ar7c4: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Genentech / Roche - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their o",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c4",
        "label": "Q3ar4c4: Other type of person (Specify): - Genentech / Roche - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c4",
        "label": "Q3ar5c4: Other type of person (Specify): - Genentech / Roche - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c5",
        "label": "Q3ar1c5: Product sales representative - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c5",
        "label": "Q3ar2c5: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c5",
        "label": "Q3ar8c5: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Pfizer - For each of these companies, to the best of your ability, please indic",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c5",
        "label": "Q3ar9c5: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c5",
        "label": "Q3ar3c5: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c5",
        "label": "Q3ar7c5: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology dru",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c5",
        "label": "Q3ar4c5: Other type of person (Specify): - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c5",
        "label": "Q3ar5c5: Other type of person (Specify): - Pfizer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c6",
        "label": "Q3ar1c6: Product sales representative - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c6",
        "label": "Q3ar2c6: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of perso",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c6",
        "label": "Q3ar8c6: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Janssen / Johnson & Johnson - For each of these companies, to the best of your",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c6",
        "label": "Q3ar9c6: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of perso",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c6",
        "label": "Q3ar3c6: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personne",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c6",
        "label": "Q3ar7c6: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c6",
        "label": "Q3ar4c6: Other type of person (Specify): - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c6",
        "label": "Q3ar5c6: Other type of person (Specify): - Janssen / Johnson & Johnson - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c7",
        "label": "Q3ar1c7: Product sales representative - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c7",
        "label": "Q3ar2c7: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interact",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c7",
        "label": "Q3ar8c7: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Bayer - For each of these companies, to the best of your ability, please indica",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c7",
        "label": "Q3ar9c7: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interact",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c7",
        "label": "Q3ar3c7: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c7",
        "label": "Q3ar7c7: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drug",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c7",
        "label": "Q3ar4c7: Other type of person (Specify): - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c7",
        "label": "Q3ar5c7: Other type of person (Specify): - Bayer - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c8",
        "label": "Q3ar1c8: Product sales representative - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c8",
        "label": "Q3ar2c8: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c8",
        "label": "Q3ar8c8: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Abbvie - For each of these companies, to the best of your ability, please indic",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c8",
        "label": "Q3ar9c8: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c8",
        "label": "Q3ar3c8: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c8",
        "label": "Q3ar7c8: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology dru",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c8",
        "label": "Q3ar4c8: Other type of person (Specify): - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c8",
        "label": "Q3ar5c8: Other type of person (Specify): - Abbvie - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c9",
        "label": "Q3ar1c9: Product sales representative - Sanofi - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c9",
        "label": "Q3ar2c9: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Sanofi - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c9",
        "label": "Q3ar8c9: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Sanofi - For each of these companies, to the best of your ability, please indic",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c9",
        "label": "Q3ar9c9: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Sanofi - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c9",
        "label": "Q3ar3c9: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Sanofi - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c9",
        "label": "Q3ar7c9: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Sanofi - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology dru",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c9",
        "label": "Q3ar4c9: Other type of person (Specify): - Sanofi - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c9",
        "label": "Q3ar5c9: Other type of person (Specify): - Sanofi - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c10",
        "label": "Q3ar1c10: Product sales representative - Lilly - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c10",
        "label": "Q3ar2c10: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Lilly - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c10",
        "label": "Q3ar8c10: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Lilly - For each of these companies, to the best of your ability, please indic",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c10",
        "label": "Q3ar9c10: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Lilly - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c10",
        "label": "Q3ar3c10: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Lilly - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c10",
        "label": "Q3ar7c10: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Lilly - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology dru",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c10",
        "label": "Q3ar4c10: Other type of person (Specify): - Lilly - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c10",
        "label": "Q3ar5c10: Other type of person (Specify): - Lilly - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c11",
        "label": "Q3ar1c11: Product sales representative - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c11",
        "label": "Q3ar2c11: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inte",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c11",
        "label": "Q3ar8c11: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Novartis - For each of these companies, to the best of your ability, please in",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c11",
        "label": "Q3ar9c11: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inte",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c11",
        "label": "Q3ar3c11: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c11",
        "label": "Q3ar7c11: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c11",
        "label": "Q3ar4c11: Other type of person (Specify): - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c11",
        "label": "Q3ar5c11: Other type of person (Specify): - Novartis - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c12",
        "label": "Q3ar1c12: Product sales representative - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c12",
        "label": "Q3ar2c12: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you hav",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c12",
        "label": "Q3ar8c12: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Daiichi-Sankyo - For each of these companies, to the best of your ability, ple",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c12",
        "label": "Q3ar9c12: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you hav",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c12",
        "label": "Q3ar3c12: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have i",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c12",
        "label": "Q3ar7c12: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their onc",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c12",
        "label": "Q3ar4c12: Other type of person (Specify): - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c12",
        "label": "Q3ar5c12: Other type of person (Specify): - Daiichi-Sankyo - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c13",
        "label": "Q3ar1c13: Product sales representative - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c13",
        "label": "Q3ar2c13: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c13",
        "label": "Q3ar8c13: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Amgen - For each of these companies, to the best of your ability, please indic",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c13",
        "label": "Q3ar9c13: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c13",
        "label": "Q3ar3c13: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c13",
        "label": "Q3ar7c13: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology dru",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c13",
        "label": "Q3ar4c13: Other type of person (Specify): - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c13",
        "label": "Q3ar5c13: Other type of person (Specify): - Amgen - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c14",
        "label": "Q3ar1c14: Product sales representative - Seattle Genetics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c14",
        "label": "Q3ar2c14: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Seattle Genetics - For each of these companies, to the best of your ability, please indicate all the types of personnel you h",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c14",
        "label": "Q3ar8c14: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Seattle Genetics - For each of these companies, to the best of your ability, p",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c14",
        "label": "Q3ar9c14: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Seattle Genetics - For each of these companies, to the best of your ability, please indicate all the types of personnel you h",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c14",
        "label": "Q3ar3c14: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Seattle Genetics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c14",
        "label": "Q3ar7c14: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Seattle Genetics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their o",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c14",
        "label": "Q3ar4c14: Other type of person (Specify): - Seattle Genetics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c14",
        "label": "Q3ar5c14: Other type of person (Specify): - Seattle Genetics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c15",
        "label": "Q3ar1c15: Product sales representative - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c15",
        "label": "Q3ar2c15: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacte",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c15",
        "label": "Q3ar8c15: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - GSK - For each of these companies, to the best of your ability, please indicat",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c15",
        "label": "Q3ar9c15: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacte",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c15",
        "label": "Q3ar3c15: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted w",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c15",
        "label": "Q3ar7c15: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c15",
        "label": "Q3ar4c15: Other type of person (Specify): - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c15",
        "label": "Q3ar5c15: Other type of person (Specify): - GSK - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c16",
        "label": "Q3ar1c16: Product sales representative - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c16",
        "label": "Q3ar2c16: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have i",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c16",
        "label": "Q3ar8c16: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - AstraZeneca - For each of these companies, to the best of your ability, please",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c16",
        "label": "Q3ar9c16: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have i",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c16",
        "label": "Q3ar3c16: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have inte",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c16",
        "label": "Q3ar7c16: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncolo",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c16",
        "label": "Q3ar4c16: Other type of person (Specify): - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c16",
        "label": "Q3ar5c16: Other type of person (Specify): - AstraZeneca - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar1c17",
        "label": "Q3ar1c17: Product sales representative - Gilead / Immunomedics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar2c17",
        "label": "Q3ar2c17: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Gilead / Immunomedics - For each of these companies, to the best of your ability, please indicate all the types of personnel",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar8c17",
        "label": "Q3ar8c17: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Gilead / Immunomedics - For each of these companies, to the best of your abili",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar9c17",
        "label": "Q3ar9c17: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Gilead / Immunomedics - For each of these companies, to the best of your ability, please indicate all the types of personnel",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar3c17",
        "label": "Q3ar3c17: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Gilead / Immunomedics - For each of these companies, to the best of your ability, please indicate all the types of personnel you",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar7c17",
        "label": "Q3ar7c17: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Gilead / Immunomedics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to th",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar4c17",
        "label": "Q3ar4c17: Other type of person (Specify): - Gilead / Immunomedics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q3ar5c17",
        "label": "Q3ar5c17: Other type of person (Specify): - Gilead / Immunomedics - For each of these companies, to the best of your ability, please indicate all the types of personnel you have interacted with related to their oncology drugs in the past 6 months.",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q4",
    "questionText": "Q4",
    "items": [
      {
        "column": "Q4r1",
        "label": "Q4r1: Is a company I trust - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutical company with oncology drugs. It is important",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r2",
        "label": "Q4r2: Puts patients first - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutical company with oncology drugs. It is important t",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r3",
        "label": "Q4r3: Enables timely and reliable access to medications - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutical company with onc",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r4",
        "label": "Q4r4: Provides a breadth of financial assistance options for patients - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutical co",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r5",
        "label": "Q4r5: Invests in oncology clinical trials/pipeline - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutical company with oncology",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r6",
        "label": "Q4r6: [pipe: Q4_row6] - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutical company with oncology drugs. It is important that",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r7",
        "label": "Q4r7: Provides support services (non-financial) to patients and caregivers - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutic",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r8",
        "label": "Q4r8: Has a useful and easy-to-use website - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a pharmaceutical company with oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r9",
        "label": "Q4r9: Is focused on developing treatments for cancers with limited treatment options - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes are for a ph",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q4r10",
        "label": "Q4r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Please think about the pharmaceutical companies that you interact with most often for oncology drugs.Please indicate how important the following attributes",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q5",
    "questionText": "Q5",
    "items": [
      {
        "column": "Q5r1",
        "label": "Q5r1: Have a presence in my practice / frequent touchpoints - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please ind",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r2",
        "label": "Q5r2: Demonstrate in-depth knowledge of treatment area - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicate",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r3",
        "label": "Q5r3: Deliver quality product information and education - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicat",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r4",
        "label": "Q5r4: Understand my practice - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicate how important the followi",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r5",
        "label": "Q5r5: Are responsive and dependable - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicate how important the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r6",
        "label": "Q5r6: Are collaborative - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicate how important the following at",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r7",
        "label": "Q5r7: Are helpful in securing timely product access - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicate ho",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r8",
        "label": "Q5r8: Make my job easier by reducing hassles to prescribing - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please ind",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r9",
        "label": "Q5r9: Give me confidence I am making the right treatment decisions - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Ple",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r10",
        "label": "Q5r10: Are warm and friendly - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicate how important the followi",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      },
      {
        "column": "Q5r11",
        "label": "Q5r11: Are adaptable to the current environment - Now please think about the personnel from these companies (including reps, account managers, MSLs, access/ reimbursement managers, and any other people that you might interact with). Please indicate how im",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Important1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Important10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr1",
    "questionText": "Q6_Lr1",
    "items": [
      {
        "column": "Q6_Lr1r1",
        "label": "Q6_Lr1r1: Is a company I trust - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r2",
        "label": "Q6_Lr1r2: Puts patients first - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r3",
        "label": "Q6_Lr1r3: Enables timely and reliable access to medications - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r4",
        "label": "Q6_Lr1r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r5",
        "label": "Q6_Lr1r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r6",
        "label": "Q6_Lr1r6: [pipe: Q4_row6] - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r7",
        "label": "Q6_Lr1r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r8",
        "label": "Q6_Lr1r8: Has a useful and easy-to-use website - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r9",
        "label": "Q6_Lr1r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      },
      {
        "column": "Q6_Lr1r10",
        "label": "Q6_Lr1r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Astellas on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          },
          {
            "value": 11,
            "label": "DON’T KNOW"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr2",
    "questionText": "Q6_Lr2",
    "items": [
      {
        "column": "Q6_Lr2r1",
        "label": "Q6_Lr2r1: Is a company I trust - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r2",
        "label": "Q6_Lr2r2: Puts patients first - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r3",
        "label": "Q6_Lr2r3: Enables timely and reliable access to medications - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r4",
        "label": "Q6_Lr2r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r5",
        "label": "Q6_Lr2r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r6",
        "label": "Q6_Lr2r6: [pipe: Q4_row6] - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r7",
        "label": "Q6_Lr2r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r8",
        "label": "Q6_Lr2r8: Has a useful and easy-to-use website - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r9",
        "label": "Q6_Lr2r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr2r10",
        "label": "Q6_Lr2r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Merck / EMD Serono on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr3",
    "questionText": "Q6_Lr3",
    "items": [
      {
        "column": "Q6_Lr3r1",
        "label": "Q6_Lr3r1: Is a company I trust - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r2",
        "label": "Q6_Lr3r2: Puts patients first - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r3",
        "label": "Q6_Lr3r3: Enables timely and reliable access to medications - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r4",
        "label": "Q6_Lr3r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r5",
        "label": "Q6_Lr3r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r6",
        "label": "Q6_Lr3r6: [pipe: Q4_row6] - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r7",
        "label": "Q6_Lr3r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r8",
        "label": "Q6_Lr3r8: Has a useful and easy-to-use website - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r9",
        "label": "Q6_Lr3r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr3r10",
        "label": "Q6_Lr3r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Bristol-Myers Squibb (BMS) on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr4",
    "questionText": "Q6_Lr4",
    "items": [
      {
        "column": "Q6_Lr4r1",
        "label": "Q6_Lr4r1: Is a company I trust - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r2",
        "label": "Q6_Lr4r2: Puts patients first - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r3",
        "label": "Q6_Lr4r3: Enables timely and reliable access to medications - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r4",
        "label": "Q6_Lr4r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r5",
        "label": "Q6_Lr4r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r6",
        "label": "Q6_Lr4r6: [pipe: Q4_row6] - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r7",
        "label": "Q6_Lr4r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r8",
        "label": "Q6_Lr4r8: Has a useful and easy-to-use website - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r9",
        "label": "Q6_Lr4r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr4r10",
        "label": "Q6_Lr4r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Genentech / Roche on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr5",
    "questionText": "Q6_Lr5",
    "items": [
      {
        "column": "Q6_Lr5r1",
        "label": "Q6_Lr5r1: Is a company I trust - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r2",
        "label": "Q6_Lr5r2: Puts patients first - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r3",
        "label": "Q6_Lr5r3: Enables timely and reliable access to medications - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r4",
        "label": "Q6_Lr5r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r5",
        "label": "Q6_Lr5r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r6",
        "label": "Q6_Lr5r6: [pipe: Q4_row6] - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r7",
        "label": "Q6_Lr5r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r8",
        "label": "Q6_Lr5r8: Has a useful and easy-to-use website - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r9",
        "label": "Q6_Lr5r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr5r10",
        "label": "Q6_Lr5r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Pfizer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr6",
    "questionText": "Q6_Lr6",
    "items": [
      {
        "column": "Q6_Lr6r1",
        "label": "Q6_Lr6r1: Is a company I trust - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r2",
        "label": "Q6_Lr6r2: Puts patients first - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r3",
        "label": "Q6_Lr6r3: Enables timely and reliable access to medications - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r4",
        "label": "Q6_Lr6r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r5",
        "label": "Q6_Lr6r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r6",
        "label": "Q6_Lr6r6: [pipe: Q4_row6] - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r7",
        "label": "Q6_Lr6r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r8",
        "label": "Q6_Lr6r8: Has a useful and easy-to-use website - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r9",
        "label": "Q6_Lr6r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr6r10",
        "label": "Q6_Lr6r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Janssen / Johnson & Johnson on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr7",
    "questionText": "Q6_Lr7",
    "items": [
      {
        "column": "Q6_Lr7r1",
        "label": "Q6_Lr7r1: Is a company I trust - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r2",
        "label": "Q6_Lr7r2: Puts patients first - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r3",
        "label": "Q6_Lr7r3: Enables timely and reliable access to medications - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r4",
        "label": "Q6_Lr7r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r5",
        "label": "Q6_Lr7r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r6",
        "label": "Q6_Lr7r6: [pipe: Q4_row6] - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r7",
        "label": "Q6_Lr7r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r8",
        "label": "Q6_Lr7r8: Has a useful and easy-to-use website - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r9",
        "label": "Q6_Lr7r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr7r10",
        "label": "Q6_Lr7r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Bayer on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr8",
    "questionText": "Q6_Lr8",
    "items": [
      {
        "column": "Q6_Lr8r1",
        "label": "Q6_Lr8r1: Is a company I trust - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r2",
        "label": "Q6_Lr8r2: Puts patients first - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r3",
        "label": "Q6_Lr8r3: Enables timely and reliable access to medications - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r4",
        "label": "Q6_Lr8r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r5",
        "label": "Q6_Lr8r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r6",
        "label": "Q6_Lr8r6: [pipe: Q4_row6] - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r7",
        "label": "Q6_Lr8r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r8",
        "label": "Q6_Lr8r8: Has a useful and easy-to-use website - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r9",
        "label": "Q6_Lr8r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr8r10",
        "label": "Q6_Lr8r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Abbvie on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr9",
    "questionText": "Q6_Lr9",
    "items": [
      {
        "column": "Q6_Lr9r1",
        "label": "Q6_Lr9r1: Is a company I trust - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r2",
        "label": "Q6_Lr9r2: Puts patients first - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r3",
        "label": "Q6_Lr9r3: Enables timely and reliable access to medications - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r4",
        "label": "Q6_Lr9r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r5",
        "label": "Q6_Lr9r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r6",
        "label": "Q6_Lr9r6: [pipe: Q4_row6] - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r7",
        "label": "Q6_Lr9r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r8",
        "label": "Q6_Lr9r8: Has a useful and easy-to-use website - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r9",
        "label": "Q6_Lr9r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr9r10",
        "label": "Q6_Lr9r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Sanofi on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr10",
    "questionText": "Q6_Lr10",
    "items": [
      {
        "column": "Q6_Lr10r1",
        "label": "Q6_Lr10r1: Is a company I trust - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r2",
        "label": "Q6_Lr10r2: Puts patients first - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r3",
        "label": "Q6_Lr10r3: Enables timely and reliable access to medications - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r4",
        "label": "Q6_Lr10r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r5",
        "label": "Q6_Lr10r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r6",
        "label": "Q6_Lr10r6: [pipe: Q4_row6] - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r7",
        "label": "Q6_Lr10r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r8",
        "label": "Q6_Lr10r8: Has a useful and easy-to-use website - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r9",
        "label": "Q6_Lr10r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr10r10",
        "label": "Q6_Lr10r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Lilly on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr11",
    "questionText": "Q6_Lr11",
    "items": [
      {
        "column": "Q6_Lr11r1",
        "label": "Q6_Lr11r1: Is a company I trust - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r2",
        "label": "Q6_Lr11r2: Puts patients first - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r3",
        "label": "Q6_Lr11r3: Enables timely and reliable access to medications - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r4",
        "label": "Q6_Lr11r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r5",
        "label": "Q6_Lr11r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r6",
        "label": "Q6_Lr11r6: [pipe: Q4_row6] - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r7",
        "label": "Q6_Lr11r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r8",
        "label": "Q6_Lr11r8: Has a useful and easy-to-use website - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r9",
        "label": "Q6_Lr11r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr11r10",
        "label": "Q6_Lr11r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Novartis on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr12",
    "questionText": "Q6_Lr12",
    "items": [
      {
        "column": "Q6_Lr12r1",
        "label": "Q6_Lr12r1: Is a company I trust - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r2",
        "label": "Q6_Lr12r2: Puts patients first - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r3",
        "label": "Q6_Lr12r3: Enables timely and reliable access to medications - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r4",
        "label": "Q6_Lr12r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r5",
        "label": "Q6_Lr12r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r6",
        "label": "Q6_Lr12r6: [pipe: Q4_row6] - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r7",
        "label": "Q6_Lr12r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r8",
        "label": "Q6_Lr12r8: Has a useful and easy-to-use website - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r9",
        "label": "Q6_Lr12r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr12r10",
        "label": "Q6_Lr12r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Daiichi-Sankyo on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr13",
    "questionText": "Q6_Lr13",
    "items": [
      {
        "column": "Q6_Lr13r1",
        "label": "Q6_Lr13r1: Is a company I trust - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r2",
        "label": "Q6_Lr13r2: Puts patients first - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r3",
        "label": "Q6_Lr13r3: Enables timely and reliable access to medications - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r4",
        "label": "Q6_Lr13r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r5",
        "label": "Q6_Lr13r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r6",
        "label": "Q6_Lr13r6: [pipe: Q4_row6] - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r7",
        "label": "Q6_Lr13r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r8",
        "label": "Q6_Lr13r8: Has a useful and easy-to-use website - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r9",
        "label": "Q6_Lr13r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr13r10",
        "label": "Q6_Lr13r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Amgen on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr14",
    "questionText": "Q6_Lr14",
    "items": [
      {
        "column": "Q6_Lr14r1",
        "label": "Q6_Lr14r1: Is a company I trust - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r2",
        "label": "Q6_Lr14r2: Puts patients first - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r3",
        "label": "Q6_Lr14r3: Enables timely and reliable access to medications - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r4",
        "label": "Q6_Lr14r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r5",
        "label": "Q6_Lr14r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r6",
        "label": "Q6_Lr14r6: [pipe: Q4_row6] - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r7",
        "label": "Q6_Lr14r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r8",
        "label": "Q6_Lr14r8: Has a useful and easy-to-use website - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r9",
        "label": "Q6_Lr14r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr14r10",
        "label": "Q6_Lr14r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Seattle Genetics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr15",
    "questionText": "Q6_Lr15",
    "items": [
      {
        "column": "Q6_Lr15r1",
        "label": "Q6_Lr15r1: Is a company I trust - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r2",
        "label": "Q6_Lr15r2: Puts patients first - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r3",
        "label": "Q6_Lr15r3: Enables timely and reliable access to medications - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r4",
        "label": "Q6_Lr15r4: Provides a variety of financial assistance options for patients - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r5",
        "label": "Q6_Lr15r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r6",
        "label": "Q6_Lr15r6: [pipe: Q4_row6] - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r7",
        "label": "Q6_Lr15r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r8",
        "label": "Q6_Lr15r8: Has a useful and easy-to-use website - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r9",
        "label": "Q6_Lr15r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr15r10",
        "label": "Q6_Lr15r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with GSK on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr16",
    "questionText": "Q6_Lr16",
    "items": [
      {
        "column": "Q6_Lr16r1",
        "label": "Q6_Lr16r1: Is a company I trust - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r2",
        "label": "Q6_Lr16r2: Puts patients first - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r3",
        "label": "Q6_Lr16r3: Enables timely and reliable access to medications - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r4",
        "label": "Q6_Lr16r4: Provides a variety of financial assistance options for patients - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r5",
        "label": "Q6_Lr16r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r6",
        "label": "Q6_Lr16r6: [pipe: Q4_row6] - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r7",
        "label": "Q6_Lr16r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r8",
        "label": "Q6_Lr16r8: Has a useful and easy-to-use website - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r9",
        "label": "Q6_Lr16r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr16r10",
        "label": "Q6_Lr16r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with AstraZeneca on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q6_Lr17",
    "questionText": "Q6_Lr17",
    "items": [
      {
        "column": "Q6_Lr17r1",
        "label": "Q6_Lr17r1: Is a company I trust - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r2",
        "label": "Q6_Lr17r2: Puts patients first - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r3",
        "label": "Q6_Lr17r3: Enables timely and reliable access to medications - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r4",
        "label": "Q6_Lr17r4: Provides a variety of financial assistance options for patients - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r5",
        "label": "Q6_Lr17r5: Invests in oncology clinical trials/pipeline - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r6",
        "label": "Q6_Lr17r6: [pipe: Q4_row6] - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r7",
        "label": "Q6_Lr17r7: Provides support services (non-financial) to patients and caregivers - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r8",
        "label": "Q6_Lr17r8: Has a useful and easy-to-use website - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r9",
        "label": "Q6_Lr17r9: Is focused on developing treatments for cancers with limited treatment options - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q6_Lr17r10",
        "label": "Q6_Lr17r10: Demonstrates corporate or social responsibility through community involvement/partnerships - Now please rate your experience with Gilead / Immunomedics on the following attributes.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr1",
    "questionText": "Q7_Lr1",
    "items": [
      {
        "column": "Q7_Lr1r1",
        "label": "Q7_Lr1r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r2",
        "label": "Q7_Lr1r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MSL",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r3",
        "label": "Q7_Lr1r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MS",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r4",
        "label": "Q7_Lr1r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement m",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r5",
        "label": "Q7_Lr1r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MSLs, access/ reimburs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r6",
        "label": "Q7_Lr1r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manage",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r7",
        "label": "Q7_Lr1r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r8",
        "label": "Q7_Lr1r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r9",
        "label": "Q7_Lr1r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account m",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r10",
        "label": "Q7_Lr1r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement m",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr1r11",
        "label": "Q7_Lr1r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the following attributes. These can be reps, account managers, MSLs, acce",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr2",
    "questionText": "Q7_Lr2",
    "items": [
      {
        "column": "Q7_Lr2r1",
        "label": "Q7_Lr2r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, accoun",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r2",
        "label": "Q7_Lr2r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r3",
        "label": "Q7_Lr2r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account ma",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r4",
        "label": "Q7_Lr2r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account managers, MSLs, access/ reimb",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r5",
        "label": "Q7_Lr2r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account managers, MSLs, access",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r6",
        "label": "Q7_Lr2r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account managers, MSLs, access/ reimbursem",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r7",
        "label": "Q7_Lr2r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account manage",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r8",
        "label": "Q7_Lr2r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, accoun",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r9",
        "label": "Q7_Lr2r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r10",
        "label": "Q7_Lr2r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account managers, MSLs, access/ reimb",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr2r11",
        "label": "Q7_Lr2r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr3",
    "questionText": "Q7_Lr3",
    "items": [
      {
        "column": "Q7_Lr3r1",
        "label": "Q7_Lr3r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r2",
        "label": "Q7_Lr3r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, acc",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r3",
        "label": "Q7_Lr3r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r4",
        "label": "Q7_Lr3r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, account managers, MSLs, acces",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r5",
        "label": "Q7_Lr3r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, account managers, MSLs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r6",
        "label": "Q7_Lr3r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, account managers, MSLs, access/ re",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r7",
        "label": "Q7_Lr3r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, accoun",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r8",
        "label": "Q7_Lr3r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r9",
        "label": "Q7_Lr3r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r10",
        "label": "Q7_Lr3r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, account managers, MSLs, acces",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr3r11",
        "label": "Q7_Lr3r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the following attributes. These can be reps, account ma",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr4",
    "questionText": "Q7_Lr4",
    "items": [
      {
        "column": "Q7_Lr4r1",
        "label": "Q7_Lr4r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r2",
        "label": "Q7_Lr4r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r3",
        "label": "Q7_Lr4r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r4",
        "label": "Q7_Lr4r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account managers, MSLs, access/ reimbu",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r5",
        "label": "Q7_Lr4r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account managers, MSLs, access/",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r6",
        "label": "Q7_Lr4r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account managers, MSLs, access/ reimburseme",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r7",
        "label": "Q7_Lr4r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account manager",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r8",
        "label": "Q7_Lr4r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r9",
        "label": "Q7_Lr4r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r10",
        "label": "Q7_Lr4r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account managers, MSLs, access/ reimbu",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr4r11",
        "label": "Q7_Lr4r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the following attributes. These can be reps, account managers, M",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr5",
    "questionText": "Q7_Lr5",
    "items": [
      {
        "column": "Q7_Lr5r1",
        "label": "Q7_Lr5r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r2",
        "label": "Q7_Lr5r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r3",
        "label": "Q7_Lr5r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r4",
        "label": "Q7_Lr5r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r5",
        "label": "Q7_Lr5r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs, access/ reimbursem",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r6",
        "label": "Q7_Lr5r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r7",
        "label": "Q7_Lr5r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r8",
        "label": "Q7_Lr5r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r9",
        "label": "Q7_Lr5r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r10",
        "label": "Q7_Lr5r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr5r11",
        "label": "Q7_Lr5r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the following attributes. These can be reps, account managers, MSLs, access",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr6",
    "questionText": "Q7_Lr6",
    "items": [
      {
        "column": "Q7_Lr6r1",
        "label": "Q7_Lr6r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be rep",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r2",
        "label": "Q7_Lr6r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r3",
        "label": "Q7_Lr6r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r4",
        "label": "Q7_Lr6r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, account managers, MSLs, acce",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r5",
        "label": "Q7_Lr6r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, account managers, MSL",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r6",
        "label": "Q7_Lr6r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, account managers, MSLs, access/ r",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r7",
        "label": "Q7_Lr6r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, accou",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r8",
        "label": "Q7_Lr6r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be rep",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r9",
        "label": "Q7_Lr6r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r10",
        "label": "Q7_Lr6r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, account managers, MSLs, acce",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr6r11",
        "label": "Q7_Lr6r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the following attributes. These can be reps, account m",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr7",
    "questionText": "Q7_Lr7",
    "items": [
      {
        "column": "Q7_Lr7r1",
        "label": "Q7_Lr7r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, M",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r2",
        "label": "Q7_Lr7r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r3",
        "label": "Q7_Lr7r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r4",
        "label": "Q7_Lr7r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r5",
        "label": "Q7_Lr7r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs, access/ reimburseme",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r6",
        "label": "Q7_Lr7r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r7",
        "label": "Q7_Lr7r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs, acc",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r8",
        "label": "Q7_Lr7r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, M",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r9",
        "label": "Q7_Lr7r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r10",
        "label": "Q7_Lr7r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr7r11",
        "label": "Q7_Lr7r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the following attributes. These can be reps, account managers, MSLs, access/",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr8",
    "questionText": "Q7_Lr8",
    "items": [
      {
        "column": "Q7_Lr8r1",
        "label": "Q7_Lr8r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r2",
        "label": "Q7_Lr8r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r3",
        "label": "Q7_Lr8r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r4",
        "label": "Q7_Lr8r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r5",
        "label": "Q7_Lr8r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs, access/ reimbursem",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r6",
        "label": "Q7_Lr8r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r7",
        "label": "Q7_Lr8r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r8",
        "label": "Q7_Lr8r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r9",
        "label": "Q7_Lr8r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r10",
        "label": "Q7_Lr8r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr8r11",
        "label": "Q7_Lr8r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the following attributes. These can be reps, account managers, MSLs, access",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr9",
    "questionText": "Q7_Lr9",
    "items": [
      {
        "column": "Q7_Lr9r1",
        "label": "Q7_Lr9r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r2",
        "label": "Q7_Lr9r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r3",
        "label": "Q7_Lr9r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r4",
        "label": "Q7_Lr9r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r5",
        "label": "Q7_Lr9r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs, access/ reimbursem",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r6",
        "label": "Q7_Lr9r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r7",
        "label": "Q7_Lr9r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r8",
        "label": "Q7_Lr9r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r9",
        "label": "Q7_Lr9r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r10",
        "label": "Q7_Lr9r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr9r11",
        "label": "Q7_Lr9r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the following attributes. These can be reps, account managers, MSLs, access",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr10",
    "questionText": "Q7_Lr10",
    "items": [
      {
        "column": "Q7_Lr10r1",
        "label": "Q7_Lr10r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r2",
        "label": "Q7_Lr10r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r3",
        "label": "Q7_Lr10r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r4",
        "label": "Q7_Lr10r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r5",
        "label": "Q7_Lr10r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs, access/ reimbursem",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r6",
        "label": "Q7_Lr10r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r7",
        "label": "Q7_Lr10r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r8",
        "label": "Q7_Lr10r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r9",
        "label": "Q7_Lr10r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r10",
        "label": "Q7_Lr10r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr10r11",
        "label": "Q7_Lr10r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the following attributes. These can be reps, account managers, MSLs, access",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr11",
    "questionText": "Q7_Lr11",
    "items": [
      {
        "column": "Q7_Lr11r1",
        "label": "Q7_Lr11r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account manager",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r2",
        "label": "Q7_Lr11r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, MS",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r3",
        "label": "Q7_Lr11r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, M",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r4",
        "label": "Q7_Lr11r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r5",
        "label": "Q7_Lr11r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, MSLs, access/ reimbur",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r6",
        "label": "Q7_Lr11r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r7",
        "label": "Q7_Lr11r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r8",
        "label": "Q7_Lr11r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account manager",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r9",
        "label": "Q7_Lr11r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r10",
        "label": "Q7_Lr11r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr11r11",
        "label": "Q7_Lr11r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the following attributes. These can be reps, account managers, MSLs, acc",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr12",
    "questionText": "Q7_Lr12",
    "items": [
      {
        "column": "Q7_Lr12r1",
        "label": "Q7_Lr12r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account m",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r2",
        "label": "Q7_Lr12r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account manage",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r3",
        "label": "Q7_Lr12r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account manag",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r4",
        "label": "Q7_Lr12r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account managers, MSLs, access/ reimburs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r5",
        "label": "Q7_Lr12r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account managers, MSLs, access/ r",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r6",
        "label": "Q7_Lr12r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r7",
        "label": "Q7_Lr12r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r8",
        "label": "Q7_Lr12r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account m",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r9",
        "label": "Q7_Lr12r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r10",
        "label": "Q7_Lr12r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account managers, MSLs, access/ reimburs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr12r11",
        "label": "Q7_Lr12r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the following attributes. These can be reps, account managers, MSL",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr13",
    "questionText": "Q7_Lr13",
    "items": [
      {
        "column": "Q7_Lr13r1",
        "label": "Q7_Lr13r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r2",
        "label": "Q7_Lr13r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r3",
        "label": "Q7_Lr13r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r4",
        "label": "Q7_Lr13r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r5",
        "label": "Q7_Lr13r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs, access/ reimbursem",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r6",
        "label": "Q7_Lr13r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r7",
        "label": "Q7_Lr13r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r8",
        "label": "Q7_Lr13r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r9",
        "label": "Q7_Lr13r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r10",
        "label": "Q7_Lr13r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr13r11",
        "label": "Q7_Lr13r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the following attributes. These can be reps, account managers, MSLs, access",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr14",
    "questionText": "Q7_Lr14",
    "items": [
      {
        "column": "Q7_Lr14r1",
        "label": "Q7_Lr14r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r2",
        "label": "Q7_Lr14r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r3",
        "label": "Q7_Lr14r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account man",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r4",
        "label": "Q7_Lr14r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account managers, MSLs, access/ reimbu",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r5",
        "label": "Q7_Lr14r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account managers, MSLs, access/",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r6",
        "label": "Q7_Lr14r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account managers, MSLs, access/ reimburseme",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r7",
        "label": "Q7_Lr14r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account manager",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r8",
        "label": "Q7_Lr14r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r9",
        "label": "Q7_Lr14r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r10",
        "label": "Q7_Lr14r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account managers, MSLs, access/ reimbu",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr14r11",
        "label": "Q7_Lr14r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the following attributes. These can be reps, account managers, M",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr15",
    "questionText": "Q7_Lr15",
    "items": [
      {
        "column": "Q7_Lr15r1",
        "label": "Q7_Lr15r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MS",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r2",
        "label": "Q7_Lr15r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs, a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r3",
        "label": "Q7_Lr15r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r4",
        "label": "Q7_Lr15r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r5",
        "label": "Q7_Lr15r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs, access/ reimbursemen",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r6",
        "label": "Q7_Lr15r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r7",
        "label": "Q7_Lr15r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs, acce",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r8",
        "label": "Q7_Lr15r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MS",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r9",
        "label": "Q7_Lr15r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account manag",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r10",
        "label": "Q7_Lr15r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement manag",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr15r11",
        "label": "Q7_Lr15r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the following attributes. These can be reps, account managers, MSLs, access/",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr16",
    "questionText": "Q7_Lr16",
    "items": [
      {
        "column": "Q7_Lr16r1",
        "label": "Q7_Lr16r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r2",
        "label": "Q7_Lr16r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r3",
        "label": "Q7_Lr16r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r4",
        "label": "Q7_Lr16r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers, MSLs, access/ reimburseme",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r5",
        "label": "Q7_Lr16r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers, MSLs, access/ reim",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r6",
        "label": "Q7_Lr16r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers, MSLs, access/ reimbursement ma",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r7",
        "label": "Q7_Lr16r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers, MS",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r8",
        "label": "Q7_Lr16r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r9",
        "label": "Q7_Lr16r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, accou",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r10",
        "label": "Q7_Lr16r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers, MSLs, access/ reimburseme",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr16r11",
        "label": "Q7_Lr16r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the following attributes. These can be reps, account managers, MSLs,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q7_Lr17",
    "questionText": "Q7_Lr17",
    "items": [
      {
        "column": "Q7_Lr17r1",
        "label": "Q7_Lr17r1: Have a presence in my practice / frequent touchpoints - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r2",
        "label": "Q7_Lr17r2: Demonstrate in-depth knowledge of treatment area - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r3",
        "label": "Q7_Lr17r3: Deliver quality product information and education - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, accoun",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r4",
        "label": "Q7_Lr17r4: Understand my practice - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, account managers, MSLs, access/ r",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r5",
        "label": "Q7_Lr17r5: Are responsive and dependable - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, account managers, MSLs, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r6",
        "label": "Q7_Lr17r6: Are collaborative - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, account managers, MSLs, access/ reimbu",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r7",
        "label": "Q7_Lr17r7: Are helpful in securing timely product access - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, account ma",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r8",
        "label": "Q7_Lr17r8: Make my job easier by reducing hassles to prescribing - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r9",
        "label": "Q7_Lr17r9: Give me confidence I am making the right treatment decisions - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be r",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r10",
        "label": "Q7_Lr17r10: Are warm and friendly - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, account managers, MSLs, access/ r",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      },
      {
        "column": "Q7_Lr17r11",
        "label": "Q7_Lr17r11: Are adaptable to the current environment - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the following attributes. These can be reps, account manage",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q8",
    "questionText": "Q8",
    "items": [
      {
        "column": "Q8r1",
        "label": "Q8r1: Astellas - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r2",
        "label": "Q8r2: Merck / EMD Serono - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r3",
        "label": "Q8r3: Bristol-Myers Squibb (BMS) - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r4",
        "label": "Q8r4: Genentech / Roche - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r5",
        "label": "Q8r5: Pfizer - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r6",
        "label": "Q8r6: Janssen / Johnson & Johnson - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r7",
        "label": "Q8r7: Bayer - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r8",
        "label": "Q8r8: Abbvie - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r9",
        "label": "Q8r9: Sanofi - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r10",
        "label": "Q8r10: Lilly - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r11",
        "label": "Q8r11: Novartis - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r12",
        "label": "Q8r12: Daiichi-Sankyo - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r13",
        "label": "Q8r13: Amgen - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r14",
        "label": "Q8r14: Seattle Genetics - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r15",
        "label": "Q8r15: GSK - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r16",
        "label": "Q8r16: AstraZeneca - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q8r17",
        "label": "Q8r17: Gilead / Immunomedics - For each of the following companies, please indicate your satisfaction with your overall relationship with the company in oncology:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9",
    "questionText": "Q9",
    "items": [
      {
        "column": "Q9c1",
        "label": "Q9c1: Best experience related to oncology overall - Which pharmaceutical company do you consider to be the best in terms of your overall experiences with them specifically related to oncology?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-18",
        "rangeMin": 1,
        "rangeMax": 18,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Astellas"
          },
          {
            "value": 2,
            "label": "Merck / EMD Serono"
          },
          {
            "value": 3,
            "label": "Bristol-Myers Squibb (BMS)"
          },
          {
            "value": 4,
            "label": "Genentech / Roche"
          },
          {
            "value": 5,
            "label": "Pfizer"
          },
          {
            "value": 6,
            "label": "Janssen / Johnson & Johnson"
          },
          {
            "value": 7,
            "label": "Bayer"
          },
          {
            "value": 8,
            "label": "Abbvie"
          },
          {
            "value": 9,
            "label": "Sanofi"
          },
          {
            "value": 10,
            "label": "Lilly"
          },
          {
            "value": 11,
            "label": "Novartis"
          },
          {
            "value": 12,
            "label": "Daiichi-Sankyo"
          },
          {
            "value": 13,
            "label": "Amgen"
          },
          {
            "value": 14,
            "label": "Seattle Genetics"
          },
          {
            "value": 15,
            "label": "GSK"
          },
          {
            "value": 16,
            "label": "AstraZeneca"
          },
          {
            "value": 17,
            "label": "Gilead / Immunomedics"
          },
          {
            "value": 18,
            "label": "Other"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9a_H",
    "questionText": "Q9a_H",
    "items": [
      {
        "column": "Q9a_Hc1",
        "label": "Q9a_Hc1: Best experience related to AML - And, which do you consider to be the best in terms of your overall experiences specifically related to AML?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-18",
        "rangeMin": 1,
        "rangeMax": 18,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Astellas"
          },
          {
            "value": 2,
            "label": "Merck / EMD Serono"
          },
          {
            "value": 3,
            "label": "Bristol-Myers Squibb (BMS)"
          },
          {
            "value": 4,
            "label": "Genentech / Roche"
          },
          {
            "value": 5,
            "label": "Pfizer"
          },
          {
            "value": 6,
            "label": "Janssen / Johnson & Johnson"
          },
          {
            "value": 7,
            "label": "Bayer"
          },
          {
            "value": 8,
            "label": "Abbvie"
          },
          {
            "value": 9,
            "label": "Sanofi"
          },
          {
            "value": 10,
            "label": "Lilly"
          },
          {
            "value": 11,
            "label": "Novartis"
          },
          {
            "value": 12,
            "label": "Daiichi-Sankyo"
          },
          {
            "value": 13,
            "label": "Amgen"
          },
          {
            "value": 14,
            "label": "Seattle Genetics"
          },
          {
            "value": 15,
            "label": "GSK"
          },
          {
            "value": 16,
            "label": "AstraZeneca"
          },
          {
            "value": 17,
            "label": "Gilead / Immunomedics"
          },
          {
            "value": 18,
            "label": "Other"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9a_O_U",
    "questionText": "Q9a_O_U",
    "items": [
      {
        "column": "Q9a_O_Uc1",
        "label": "Q9a_O_Uc1: Best experience related to prostate cancer - And, which do you consider to be the best in terms of your overall experiences specifically related to prostate cancer?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-18",
        "rangeMin": 1,
        "rangeMax": 18,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Astellas"
          },
          {
            "value": 2,
            "label": "Merck / EMD Serono"
          },
          {
            "value": 3,
            "label": "Bristol-Myers Squibb (BMS)"
          },
          {
            "value": 4,
            "label": "Genentech / Roche"
          },
          {
            "value": 5,
            "label": "Pfizer"
          },
          {
            "value": 6,
            "label": "Janssen / Johnson & Johnson"
          },
          {
            "value": 7,
            "label": "Bayer"
          },
          {
            "value": 8,
            "label": "Abbvie"
          },
          {
            "value": 9,
            "label": "Sanofi"
          },
          {
            "value": 10,
            "label": "Lilly"
          },
          {
            "value": 11,
            "label": "Novartis"
          },
          {
            "value": 12,
            "label": "Daiichi-Sankyo"
          },
          {
            "value": 13,
            "label": "Amgen"
          },
          {
            "value": 14,
            "label": "Seattle Genetics"
          },
          {
            "value": 15,
            "label": "GSK"
          },
          {
            "value": 16,
            "label": "AstraZeneca"
          },
          {
            "value": 17,
            "label": "Gilead / Immunomedics"
          },
          {
            "value": 18,
            "label": "Other"
          }
        ]
      }
    ]
  },
  {
    "questionId": "x9aOB",
    "questionText": "x9aOB",
    "items": [
      {
        "column": "x9aOBc1",
        "label": "x9aOBc1: Best experience related to bladder cancer - And, which do you consider to be the best in terms of your overall experiences specifically related to bladder cancer?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-18",
        "rangeMin": 1,
        "rangeMax": 18,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Astellas"
          },
          {
            "value": 2,
            "label": "Merck / EMD Serono"
          },
          {
            "value": 3,
            "label": "Bristol-Myers Squibb (BMS)"
          },
          {
            "value": 4,
            "label": "Genentech / Roche"
          },
          {
            "value": 5,
            "label": "Pfizer"
          },
          {
            "value": 6,
            "label": "Janssen / Johnson & Johnson"
          },
          {
            "value": 7,
            "label": "Bayer"
          },
          {
            "value": 8,
            "label": "Abbvie"
          },
          {
            "value": 9,
            "label": "Sanofi"
          },
          {
            "value": 10,
            "label": "Lilly"
          },
          {
            "value": 11,
            "label": "Novartis"
          },
          {
            "value": 12,
            "label": "Daiichi-Sankyo"
          },
          {
            "value": 13,
            "label": "Amgen"
          },
          {
            "value": 14,
            "label": "Seattle Genetics"
          },
          {
            "value": 15,
            "label": "GSK"
          },
          {
            "value": 16,
            "label": "AstraZeneca"
          },
          {
            "value": 17,
            "label": "Gilead / Immunomedics"
          },
          {
            "value": 18,
            "label": "Other"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S9_LF",
    "questionText": "S9_LF",
    "items": [
      {
        "column": "S9_LFr1",
        "label": "S9_LFr1: Astellas - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr2",
        "label": "S9_LFr2: Merck / EMD Serono - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr3",
        "label": "S9_LFr3: Bristol-Myers Squibb (BMS) - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr4",
        "label": "S9_LFr4: Genentech / Roche - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr5",
        "label": "S9_LFr5: Pfizer - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr6",
        "label": "S9_LFr6: Janssen / Johnson & Johnson - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr7",
        "label": "S9_LFr7: Bayer - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr8",
        "label": "S9_LFr8: Abbvie - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr9",
        "label": "S9_LFr9: Sanofi - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr10",
        "label": "S9_LFr10: Lilly - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr11",
        "label": "S9_LFr11: Novartis - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr12",
        "label": "S9_LFr12: Daiichi-Sankyo - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr13",
        "label": "S9_LFr13: Amgen - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr14",
        "label": "S9_LFr14: Seattle Genetics - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr15",
        "label": "S9_LFr15: GSK - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr16",
        "label": "S9_LFr16: AstraZeneca - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "S9_LFr17",
        "label": "S9_LFr17: Gilead / Immunomedics - Listfill for S9",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9c",
    "questionText": "Q9c",
    "items": [
      {
        "column": "Q9cc1",
        "label": "Q9cc1: Astellas - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc2",
        "label": "Q9cc2: Merck / EMD Serono - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc3",
        "label": "Q9cc3: Bristol-Myers Squibb (BMS) - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc4",
        "label": "Q9cc4: Genentech / Roche - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc5",
        "label": "Q9cc5: Pfizer - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc6",
        "label": "Q9cc6: Janssen / Johnson & Johnson - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc7",
        "label": "Q9cc7: Bayer - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc8",
        "label": "Q9cc8: Abbvie - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc9",
        "label": "Q9cc9: Sanofi - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc10",
        "label": "Q9cc10: Lilly - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc11",
        "label": "Q9cc11: Novartis - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc12",
        "label": "Q9cc12: Daiichi-Sankyo - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc13",
        "label": "Q9cc13: Amgen - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc14",
        "label": "Q9cc14: Seattle Genetics - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc15",
        "label": "Q9cc15: GSK - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc16",
        "label": "Q9cc16: AstraZeneca - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      },
      {
        "column": "Q9cc17",
        "label": "Q9cc17: Gilead / Immunomedics - For each of company below, please indicate the MOST RECENT type of interaction you have had with them related to their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-8",
        "rangeMin": 1,
        "rangeMax": 8,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "In person discussion (i.e. at practice setting)"
          },
          {
            "value": 2,
            "label": "Virtual discussion (e.g. Zoom"
          },
          {
            "value": 3,
            "label": "Telephone call"
          },
          {
            "value": 4,
            "label": "Email communication"
          },
          {
            "value": 5,
            "label": "Conference discussion (e.g. virtual or live booth visit"
          },
          {
            "value": 6,
            "label": "Website / Online portal"
          },
          {
            "value": 7,
            "label": "Other type of interaction (Specify:)"
          },
          {
            "value": 8,
            "label": "Unsure / I don’t remember"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9d",
    "questionText": "Q9d",
    "items": [
      {
        "column": "Q9dr1c1",
        "label": "Q9dr1c1: Product sales representative - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c1",
        "label": "Q9dr2c1: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c1",
        "label": "Q9dr8c1: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Astellas - For this MOST RECENT interaction, what type of personnel did you int",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c1",
        "label": "Q9dr9c1: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c1",
        "label": "Q9dr3c1: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c1",
        "label": "Q9dr7c1: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c1",
        "label": "Q9dr4c1: Other type of person (Specify:) - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c1",
        "label": "Q9dr5c1: Did not directly interact with personnel - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c1",
        "label": "Q9dr6c1: Unsure / I don’t remember - Astellas - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c2",
        "label": "Q9dr1c2: Product sales representative - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c2",
        "label": "Q9dr2c2: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c2",
        "label": "Q9dr8c2: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel d",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c2",
        "label": "Q9dr9c2: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c2",
        "label": "Q9dr3c2: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c2",
        "label": "Q9dr7c2: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c2",
        "label": "Q9dr4c2: Other type of person (Specify:) - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c2",
        "label": "Q9dr5c2: Did not directly interact with personnel - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c2",
        "label": "Q9dr6c2: Unsure / I don’t remember - Merck / EMD Serono - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c3",
        "label": "Q9dr1c3: Product sales representative - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c3",
        "label": "Q9dr2c3: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c3",
        "label": "Q9dr8c3: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of per",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c3",
        "label": "Q9dr9c3: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c3",
        "label": "Q9dr3c3: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c3",
        "label": "Q9dr7c3: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c3",
        "label": "Q9dr4c3: Other type of person (Specify:) - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c3",
        "label": "Q9dr5c3: Did not directly interact with personnel - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c3",
        "label": "Q9dr6c3: Unsure / I don’t remember - Bristol-Myers Squibb (BMS) - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c4",
        "label": "Q9dr1c4: Product sales representative - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c4",
        "label": "Q9dr2c4: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c4",
        "label": "Q9dr8c4: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Genentech / Roche - For this MOST RECENT interaction, what type of personnel di",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c4",
        "label": "Q9dr9c4: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c4",
        "label": "Q9dr3c4: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c4",
        "label": "Q9dr7c4: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c4",
        "label": "Q9dr4c4: Other type of person (Specify:) - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c4",
        "label": "Q9dr5c4: Did not directly interact with personnel - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c4",
        "label": "Q9dr6c4: Unsure / I don’t remember - Genentech / Roche - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c5",
        "label": "Q9dr1c5: Product sales representative - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c5",
        "label": "Q9dr2c5: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c5",
        "label": "Q9dr8c5: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Pfizer - For this MOST RECENT interaction, what type of personnel did you inter",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c5",
        "label": "Q9dr9c5: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c5",
        "label": "Q9dr3c5: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c5",
        "label": "Q9dr7c5: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c5",
        "label": "Q9dr4c5: Other type of person (Specify:) - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c5",
        "label": "Q9dr5c5: Did not directly interact with personnel - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c5",
        "label": "Q9dr6c5: Unsure / I don’t remember - Pfizer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c6",
        "label": "Q9dr1c6: Product sales representative - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c6",
        "label": "Q9dr2c6: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c6",
        "label": "Q9dr8c6: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of pe",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c6",
        "label": "Q9dr9c6: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c6",
        "label": "Q9dr3c6: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c6",
        "label": "Q9dr7c6: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c6",
        "label": "Q9dr4c6: Other type of person (Specify:) - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c6",
        "label": "Q9dr5c6: Did not directly interact with personnel - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c6",
        "label": "Q9dr6c6: Unsure / I don’t remember - Janssen / Johnson & Johnson - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c7",
        "label": "Q9dr1c7: Product sales representative - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c7",
        "label": "Q9dr2c7: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c7",
        "label": "Q9dr8c7: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Bayer - For this MOST RECENT interaction, what type of personnel did you intera",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c7",
        "label": "Q9dr9c7: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c7",
        "label": "Q9dr3c7: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c7",
        "label": "Q9dr7c7: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c7",
        "label": "Q9dr4c7: Other type of person (Specify:) - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c7",
        "label": "Q9dr5c7: Did not directly interact with personnel - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c7",
        "label": "Q9dr6c7: Unsure / I don’t remember - Bayer - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c8",
        "label": "Q9dr1c8: Product sales representative - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c8",
        "label": "Q9dr2c8: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c8",
        "label": "Q9dr8c8: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Abbvie - For this MOST RECENT interaction, what type of personnel did you inter",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c8",
        "label": "Q9dr9c8: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c8",
        "label": "Q9dr3c8: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c8",
        "label": "Q9dr7c8: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c8",
        "label": "Q9dr4c8: Other type of person (Specify:) - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c8",
        "label": "Q9dr5c8: Did not directly interact with personnel - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c8",
        "label": "Q9dr6c8: Unsure / I don’t remember - Abbvie - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c9",
        "label": "Q9dr1c9: Product sales representative - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c9",
        "label": "Q9dr2c9: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c9",
        "label": "Q9dr8c9: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Sanofi - For this MOST RECENT interaction, what type of personnel did you inter",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c9",
        "label": "Q9dr9c9: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c9",
        "label": "Q9dr3c9: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c9",
        "label": "Q9dr7c9: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c9",
        "label": "Q9dr4c9: Other type of person (Specify:) - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c9",
        "label": "Q9dr5c9: Did not directly interact with personnel - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c9",
        "label": "Q9dr6c9: Unsure / I don’t remember - Sanofi - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c10",
        "label": "Q9dr1c10: Product sales representative - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c10",
        "label": "Q9dr2c10: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c10",
        "label": "Q9dr8c10: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Lilly - For this MOST RECENT interaction, what type of personnel did you inter",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c10",
        "label": "Q9dr9c10: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c10",
        "label": "Q9dr3c10: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c10",
        "label": "Q9dr7c10: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c10",
        "label": "Q9dr4c10: Other type of person (Specify:) - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c10",
        "label": "Q9dr5c10: Did not directly interact with personnel - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c10",
        "label": "Q9dr6c10: Unsure / I don’t remember - Lilly - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c11",
        "label": "Q9dr1c11: Product sales representative - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c11",
        "label": "Q9dr2c11: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c11",
        "label": "Q9dr8c11: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Novartis - For this MOST RECENT interaction, what type of personnel did you in",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c11",
        "label": "Q9dr9c11: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c11",
        "label": "Q9dr3c11: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c11",
        "label": "Q9dr7c11: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c11",
        "label": "Q9dr4c11: Other type of person (Specify:) - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c11",
        "label": "Q9dr5c11: Did not directly interact with personnel - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c11",
        "label": "Q9dr6c11: Unsure / I don’t remember - Novartis - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c12",
        "label": "Q9dr1c12: Product sales representative - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c12",
        "label": "Q9dr2c12: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c12",
        "label": "Q9dr8c12: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c12",
        "label": "Q9dr9c12: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c12",
        "label": "Q9dr3c12: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c12",
        "label": "Q9dr7c12: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c12",
        "label": "Q9dr4c12: Other type of person (Specify:) - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c12",
        "label": "Q9dr5c12: Did not directly interact with personnel - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c12",
        "label": "Q9dr6c12: Unsure / I don’t remember - Daiichi-Sankyo - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c13",
        "label": "Q9dr1c13: Product sales representative - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c13",
        "label": "Q9dr2c13: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c13",
        "label": "Q9dr8c13: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Amgen - For this MOST RECENT interaction, what type of personnel did you inter",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c13",
        "label": "Q9dr9c13: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c13",
        "label": "Q9dr3c13: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c13",
        "label": "Q9dr7c13: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c13",
        "label": "Q9dr4c13: Other type of person (Specify:) - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c13",
        "label": "Q9dr5c13: Did not directly interact with personnel - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c13",
        "label": "Q9dr6c13: Unsure / I don’t remember - Amgen - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c14",
        "label": "Q9dr1c14: Product sales representative - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c14",
        "label": "Q9dr2c14: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c14",
        "label": "Q9dr8c14: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Seattle Genetics - For this MOST RECENT interaction, what type of personnel di",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c14",
        "label": "Q9dr9c14: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c14",
        "label": "Q9dr3c14: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c14",
        "label": "Q9dr7c14: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c14",
        "label": "Q9dr4c14: Other type of person (Specify:) - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c14",
        "label": "Q9dr5c14: Did not directly interact with personnel - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c14",
        "label": "Q9dr6c14: Unsure / I don’t remember - Seattle Genetics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c15",
        "label": "Q9dr1c15: Product sales representative - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c15",
        "label": "Q9dr2c15: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c15",
        "label": "Q9dr8c15: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - GSK - For this MOST RECENT interaction, what type of personnel did you interac",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c15",
        "label": "Q9dr9c15: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c15",
        "label": "Q9dr3c15: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c15",
        "label": "Q9dr7c15: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c15",
        "label": "Q9dr4c15: Other type of person (Specify:) - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c15",
        "label": "Q9dr5c15: Did not directly interact with personnel - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c15",
        "label": "Q9dr6c15: Unsure / I don’t remember - GSK - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c16",
        "label": "Q9dr1c16: Product sales representative - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c16",
        "label": "Q9dr2c16: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c16",
        "label": "Q9dr8c16: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c16",
        "label": "Q9dr9c16: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c16",
        "label": "Q9dr3c16: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c16",
        "label": "Q9dr7c16: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c16",
        "label": "Q9dr4c16: Other type of person (Specify:) - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c16",
        "label": "Q9dr5c16: Did not directly interact with personnel - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c16",
        "label": "Q9dr6c16: Unsure / I don’t remember - AstraZeneca - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr1c17",
        "label": "Q9dr1c17: Product sales representative - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr2c17",
        "label": "Q9dr2c17: Medical science liaison (MSL) (i.e. personnel who specializes in knowledge of the therapeutic area and disease state) - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr8c17",
        "label": "Q9dr8c17: Account manager (i.e. pharmaceutical company professionals that support your organization on more strategic issues but are NOT involved in day-to-day product sales) - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personn",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr9c17",
        "label": "Q9dr9c17: Access / reimbursement manager (i.e. personnel who specializes in providing support for patient access/reimbursement) - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr3c17",
        "label": "Q9dr3c17: Other company employee (e.g. reimbursement hub representative, phone representative in corporate department, etc.) - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr7c17",
        "label": "Q9dr7c17: Third party affiliated with company (e.g. specialty pharmacy, GPO, distributor) - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr4c17",
        "label": "Q9dr4c17: Other type of person (Specify:) - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr5c17",
        "label": "Q9dr5c17: Did not directly interact with personnel - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9dr6c17",
        "label": "Q9dr6c17: Unsure / I don’t remember - Gilead / Immunomedics - For this MOST RECENT interaction, what type of personnel did you interact with?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9e",
    "questionText": "Q9e",
    "items": [
      {
        "column": "Q9er1",
        "label": "Q9er1: Astellas - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er2",
        "label": "Q9er2: Merck / EMD Serono - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er3",
        "label": "Q9er3: Bristol-Myers Squibb (BMS) - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er4",
        "label": "Q9er4: Genentech / Roche - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er5",
        "label": "Q9er5: Pfizer - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er6",
        "label": "Q9er6: Janssen / Johnson & Johnson - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er7",
        "label": "Q9er7: Bayer - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er8",
        "label": "Q9er8: Abbvie - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er9",
        "label": "Q9er9: Sanofi - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er10",
        "label": "Q9er10: Lilly - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er11",
        "label": "Q9er11: Novartis - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er12",
        "label": "Q9er12: Daiichi-Sankyo - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er13",
        "label": "Q9er13: Amgen - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er14",
        "label": "Q9er14: Seattle Genetics - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er15",
        "label": "Q9er15: GSK - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er16",
        "label": "Q9er16: AstraZeneca - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q9er17",
        "label": "Q9er17: Gilead / Immunomedics - How satisfied were you with the MOST RECENT interaction?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9G_I_Eligible",
    "questionText": "Q9G_I_Eligible",
    "items": [
      {
        "column": "Q9G_I_Eligibler2",
        "label": "Q9G_I_Eligibler2: Merck / EMD Serono - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler3",
        "label": "Q9G_I_Eligibler3: Bristol-Myers Squibb (BMS) - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler4",
        "label": "Q9G_I_Eligibler4: Genentech / Roche - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler5",
        "label": "Q9G_I_Eligibler5: Pfizer - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler6",
        "label": "Q9G_I_Eligibler6: Janssen / Johnson & Johnson - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler7",
        "label": "Q9G_I_Eligibler7: Bayer - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler8",
        "label": "Q9G_I_Eligibler8: Abbvie - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler9",
        "label": "Q9G_I_Eligibler9: Sanofi - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler10",
        "label": "Q9G_I_Eligibler10: Lilly - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler11",
        "label": "Q9G_I_Eligibler11: Novartis - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler12",
        "label": "Q9G_I_Eligibler12: Daiichi-Sankyo - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler13",
        "label": "Q9G_I_Eligibler13: Amgen - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler14",
        "label": "Q9G_I_Eligibler14: Seattle Genetics - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler15",
        "label": "Q9G_I_Eligibler15: GSK - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler16",
        "label": "Q9G_I_Eligibler16: AstraZeneca - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_I_Eligibler17",
        "label": "Q9G_I_Eligibler17: Gilead / Immunomedics - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9G_I",
    "questionText": "Q9G_I",
    "items": [
      {
        "column": "Q9G_Ir2",
        "label": "Q9G_Ir2: Merck / EMD Serono - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir3",
        "label": "Q9G_Ir3: Bristol-Myers Squibb (BMS) - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir4",
        "label": "Q9G_Ir4: Genentech / Roche - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir5",
        "label": "Q9G_Ir5: Pfizer - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir6",
        "label": "Q9G_Ir6: Janssen / Johnson & Johnson - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir7",
        "label": "Q9G_Ir7: Bayer - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir8",
        "label": "Q9G_Ir8: Abbvie - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir9",
        "label": "Q9G_Ir9: Sanofi - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir10",
        "label": "Q9G_Ir10: Lilly - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir11",
        "label": "Q9G_Ir11: Novartis - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir12",
        "label": "Q9G_Ir12: Daiichi-Sankyo - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir13",
        "label": "Q9G_Ir13: Amgen - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir14",
        "label": "Q9G_Ir14: Seattle Genetics - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir15",
        "label": "Q9G_Ir15: GSK - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir16",
        "label": "Q9G_Ir16: AstraZeneca - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9G_Ir17",
        "label": "Q9G_Ir17: Gilead / Immunomedics - Listfill for Q9G_I",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9g_L",
    "questionText": "Q9g_L",
    "items": [
      {
        "column": "Q9g_Lr1c1",
        "label": "Q9g_Lr1c1: Astellas - In the past 6 months, do you recall seeing or hearing advertising for Astellas related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr2c1",
        "label": "Q9g_Lr2c1: Merck / EMD Serono - In the past 6 months, do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr3c1",
        "label": "Q9g_Lr3c1: Bristol-Myers Squibb (BMS) - In the past 6 months, do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr4c1",
        "label": "Q9g_Lr4c1: Genentech / Roche - In the past 6 months, do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr5c1",
        "label": "Q9g_Lr5c1: Pfizer - In the past 6 months, do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr6c1",
        "label": "Q9g_Lr6c1: Janssen / Johnson & Johnson - In the past 6 months, do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr7c1",
        "label": "Q9g_Lr7c1: Bayer - In the past 6 months, do you recall seeing or hearing advertising for Bayer related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr8c1",
        "label": "Q9g_Lr8c1: Abbvie - In the past 6 months, do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr9c1",
        "label": "Q9g_Lr9c1: Sanofi - In the past 6 months, do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr10c1",
        "label": "Q9g_Lr10c1: Lilly - In the past 6 months, do you recall seeing or hearing advertising for Lilly related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr11c1",
        "label": "Q9g_Lr11c1: Novartis - In the past 6 months, do you recall seeing or hearing advertising for Novartis related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr12c1",
        "label": "Q9g_Lr12c1: Daiichi-Sankyo - In the past 6 months, do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr13c1",
        "label": "Q9g_Lr13c1: Amgen - In the past 6 months, do you recall seeing or hearing advertising for Amgen related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr14c1",
        "label": "Q9g_Lr14c1: Seattle Genetics - In the past 6 months, do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr15c1",
        "label": "Q9g_Lr15c1: GSK - In the past 6 months, do you recall seeing or hearing advertising for GSK related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr16c1",
        "label": "Q9g_Lr16c1: AstraZeneca - In the past 6 months, do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      },
      {
        "column": "Q9g_Lr17c1",
        "label": "Q9g_Lr17c1: Gilead / Immunomedics - In the past 6 months, do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          },
          {
            "value": 3,
            "label": "Unsure"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr1",
    "questionText": "Q9hNew_Lr1",
    "items": [
      {
        "column": "Q9hNew_Lr1r1",
        "label": "Q9hNew_Lr1r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r2",
        "label": "Q9hNew_Lr1r2: Information you viewed on the Astellas website - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r3",
        "label": "Q9hNew_Lr1r3: Information about Astellas you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r4",
        "label": "Q9hNew_Lr1r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r5",
        "label": "Q9hNew_Lr1r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r6",
        "label": "Q9hNew_Lr1r6: Banner ads for Astellas you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r7",
        "label": "Q9hNew_Lr1r7: Social media page for Astellas (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r8",
        "label": "Q9hNew_Lr1r8: Ads for Astellas you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r9",
        "label": "Q9hNew_Lr1r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr1r98",
        "label": "Q9hNew_Lr1r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Astellas related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr2",
    "questionText": "Q9hNew_Lr2",
    "items": [
      {
        "column": "Q9hNew_Lr2r1",
        "label": "Q9hNew_Lr2r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r2",
        "label": "Q9hNew_Lr2r2: Information you viewed on the Merck / EMD Serono website - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r3",
        "label": "Q9hNew_Lr2r3: Information about Merck / EMD Serono you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncolo",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r4",
        "label": "Q9hNew_Lr2r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r5",
        "label": "Q9hNew_Lr2r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r6",
        "label": "Q9hNew_Lr2r6: Banner ads for Merck / EMD Serono you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r7",
        "label": "Q9hNew_Lr2r7: Social media page for Merck / EMD Serono (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r8",
        "label": "Q9hNew_Lr2r8: Ads for Merck / EMD Serono you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r9",
        "label": "Q9hNew_Lr2r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr2r98",
        "label": "Q9hNew_Lr2r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Merck / EMD Serono related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr3",
    "questionText": "Q9hNew_Lr3",
    "items": [
      {
        "column": "Q9hNew_Lr3r1",
        "label": "Q9hNew_Lr3r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r2",
        "label": "Q9hNew_Lr3r2: Information you viewed on the Bristol-Myers Squibb (BMS) website - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r3",
        "label": "Q9hNew_Lr3r3: Information about Bristol-Myers Squibb (BMS) you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r4",
        "label": "Q9hNew_Lr3r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r5",
        "label": "Q9hNew_Lr3r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r6",
        "label": "Q9hNew_Lr3r6: Banner ads for Bristol-Myers Squibb (BMS) you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncolo",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r7",
        "label": "Q9hNew_Lr3r7: Social media page for Bristol-Myers Squibb (BMS) (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r8",
        "label": "Q9hNew_Lr3r8: Ads for Bristol-Myers Squibb (BMS) you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r9",
        "label": "Q9hNew_Lr3r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr3r98",
        "label": "Q9hNew_Lr3r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Bristol-Myers Squibb (BMS) related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr4",
    "questionText": "Q9hNew_Lr4",
    "items": [
      {
        "column": "Q9hNew_Lr4r1",
        "label": "Q9hNew_Lr4r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r2",
        "label": "Q9hNew_Lr4r2: Information you viewed on the Genentech / Roche website - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r3",
        "label": "Q9hNew_Lr4r3: Information about Genentech / Roche you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r4",
        "label": "Q9hNew_Lr4r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r5",
        "label": "Q9hNew_Lr4r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r6",
        "label": "Q9hNew_Lr4r6: Banner ads for Genentech / Roche you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r7",
        "label": "Q9hNew_Lr4r7: Social media page for Genentech / Roche (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r8",
        "label": "Q9hNew_Lr4r8: Ads for Genentech / Roche you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r9",
        "label": "Q9hNew_Lr4r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr4r98",
        "label": "Q9hNew_Lr4r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Genentech / Roche related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr5",
    "questionText": "Q9hNew_Lr5",
    "items": [
      {
        "column": "Q9hNew_Lr5r1",
        "label": "Q9hNew_Lr5r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r2",
        "label": "Q9hNew_Lr5r2: Information you viewed on the Pfizer website - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r3",
        "label": "Q9hNew_Lr5r3: Information about Pfizer you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r4",
        "label": "Q9hNew_Lr5r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r5",
        "label": "Q9hNew_Lr5r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r6",
        "label": "Q9hNew_Lr5r6: Banner ads for Pfizer you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r7",
        "label": "Q9hNew_Lr5r7: Social media page for Pfizer (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r8",
        "label": "Q9hNew_Lr5r8: Ads for Pfizer you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r9",
        "label": "Q9hNew_Lr5r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr5r98",
        "label": "Q9hNew_Lr5r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Pfizer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr6",
    "questionText": "Q9hNew_Lr6",
    "items": [
      {
        "column": "Q9hNew_Lr6r1",
        "label": "Q9hNew_Lr6r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r2",
        "label": "Q9hNew_Lr6r2: Information you viewed on the Janssen / Johnson & Johnson website - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r3",
        "label": "Q9hNew_Lr6r3: Information about Janssen / Johnson & Johnson you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson relat",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r4",
        "label": "Q9hNew_Lr6r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r5",
        "label": "Q9hNew_Lr6r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r6",
        "label": "Q9hNew_Lr6r6: Banner ads for Janssen / Johnson & Johnson you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their onco",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r7",
        "label": "Q9hNew_Lr6r7: Social media page for Janssen / Johnson & Johnson (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r8",
        "label": "Q9hNew_Lr6r8: Ads for Janssen / Johnson & Johnson you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r9",
        "label": "Q9hNew_Lr6r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr6r98",
        "label": "Q9hNew_Lr6r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Janssen / Johnson & Johnson related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr7",
    "questionText": "Q9hNew_Lr7",
    "items": [
      {
        "column": "Q9hNew_Lr7r1",
        "label": "Q9hNew_Lr7r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r2",
        "label": "Q9hNew_Lr7r2: Information you viewed on the Bayer website - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r3",
        "label": "Q9hNew_Lr7r3: Information about Bayer you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r4",
        "label": "Q9hNew_Lr7r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r5",
        "label": "Q9hNew_Lr7r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r6",
        "label": "Q9hNew_Lr7r6: Banner ads for Bayer you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r7",
        "label": "Q9hNew_Lr7r7: Social media page for Bayer (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r8",
        "label": "Q9hNew_Lr7r8: Ads for Bayer you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r9",
        "label": "Q9hNew_Lr7r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr7r98",
        "label": "Q9hNew_Lr7r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Bayer related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr8",
    "questionText": "Q9hNew_Lr8",
    "items": [
      {
        "column": "Q9hNew_Lr8r1",
        "label": "Q9hNew_Lr8r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r2",
        "label": "Q9hNew_Lr8r2: Information you viewed on the Abbvie website - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r3",
        "label": "Q9hNew_Lr8r3: Information about Abbvie you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r4",
        "label": "Q9hNew_Lr8r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r5",
        "label": "Q9hNew_Lr8r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r6",
        "label": "Q9hNew_Lr8r6: Banner ads for Abbvie you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r7",
        "label": "Q9hNew_Lr8r7: Social media page for Abbvie (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r8",
        "label": "Q9hNew_Lr8r8: Ads for Abbvie you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r9",
        "label": "Q9hNew_Lr8r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr8r98",
        "label": "Q9hNew_Lr8r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Abbvie related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr9",
    "questionText": "Q9hNew_Lr9",
    "items": [
      {
        "column": "Q9hNew_Lr9r1",
        "label": "Q9hNew_Lr9r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r2",
        "label": "Q9hNew_Lr9r2: Information you viewed on the Sanofi website - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r3",
        "label": "Q9hNew_Lr9r3: Information about Sanofi you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r4",
        "label": "Q9hNew_Lr9r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r5",
        "label": "Q9hNew_Lr9r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r6",
        "label": "Q9hNew_Lr9r6: Banner ads for Sanofi you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r7",
        "label": "Q9hNew_Lr9r7: Social media page for Sanofi (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r8",
        "label": "Q9hNew_Lr9r8: Ads for Sanofi you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r9",
        "label": "Q9hNew_Lr9r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr9r98",
        "label": "Q9hNew_Lr9r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Sanofi related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr10",
    "questionText": "Q9hNew_Lr10",
    "items": [
      {
        "column": "Q9hNew_Lr10r1",
        "label": "Q9hNew_Lr10r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r2",
        "label": "Q9hNew_Lr10r2: Information you viewed on the Lilly website - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r3",
        "label": "Q9hNew_Lr10r3: Information about Lilly you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r4",
        "label": "Q9hNew_Lr10r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r5",
        "label": "Q9hNew_Lr10r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r6",
        "label": "Q9hNew_Lr10r6: Banner ads for Lilly you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r7",
        "label": "Q9hNew_Lr10r7: Social media page for Lilly (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r8",
        "label": "Q9hNew_Lr10r8: Ads for Lilly you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r9",
        "label": "Q9hNew_Lr10r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr10r98",
        "label": "Q9hNew_Lr10r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Lilly related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr11",
    "questionText": "Q9hNew_Lr11",
    "items": [
      {
        "column": "Q9hNew_Lr11r1",
        "label": "Q9hNew_Lr11r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r2",
        "label": "Q9hNew_Lr11r2: Information you viewed on the Novartis website - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r3",
        "label": "Q9hNew_Lr11r3: Information about Novartis you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r4",
        "label": "Q9hNew_Lr11r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r5",
        "label": "Q9hNew_Lr11r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r6",
        "label": "Q9hNew_Lr11r6: Banner ads for Novartis you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r7",
        "label": "Q9hNew_Lr11r7: Social media page for Novartis (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r8",
        "label": "Q9hNew_Lr11r8: Ads for Novartis you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r9",
        "label": "Q9hNew_Lr11r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr11r98",
        "label": "Q9hNew_Lr11r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Novartis related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr12",
    "questionText": "Q9hNew_Lr12",
    "items": [
      {
        "column": "Q9hNew_Lr12r1",
        "label": "Q9hNew_Lr12r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r2",
        "label": "Q9hNew_Lr12r2: Information you viewed on the Daiichi-Sankyo website - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r3",
        "label": "Q9hNew_Lr12r3: Information about Daiichi-Sankyo you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology port",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r4",
        "label": "Q9hNew_Lr12r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r5",
        "label": "Q9hNew_Lr12r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r6",
        "label": "Q9hNew_Lr12r6: Banner ads for Daiichi-Sankyo you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r7",
        "label": "Q9hNew_Lr12r7: Social media page for Daiichi-Sankyo (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r8",
        "label": "Q9hNew_Lr12r8: Ads for Daiichi-Sankyo you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r9",
        "label": "Q9hNew_Lr12r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr12r98",
        "label": "Q9hNew_Lr12r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Daiichi-Sankyo related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr13",
    "questionText": "Q9hNew_Lr13",
    "items": [
      {
        "column": "Q9hNew_Lr13r1",
        "label": "Q9hNew_Lr13r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r2",
        "label": "Q9hNew_Lr13r2: Information you viewed on the Amgen website - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r3",
        "label": "Q9hNew_Lr13r3: Information about Amgen you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r4",
        "label": "Q9hNew_Lr13r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r5",
        "label": "Q9hNew_Lr13r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r6",
        "label": "Q9hNew_Lr13r6: Banner ads for Amgen you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r7",
        "label": "Q9hNew_Lr13r7: Social media page for Amgen (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r8",
        "label": "Q9hNew_Lr13r8: Ads for Amgen you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r9",
        "label": "Q9hNew_Lr13r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr13r98",
        "label": "Q9hNew_Lr13r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Amgen related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr14",
    "questionText": "Q9hNew_Lr14",
    "items": [
      {
        "column": "Q9hNew_Lr14r1",
        "label": "Q9hNew_Lr14r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r2",
        "label": "Q9hNew_Lr14r2: Information you viewed on the Seattle Genetics website - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r3",
        "label": "Q9hNew_Lr14r3: Information about Seattle Genetics you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r4",
        "label": "Q9hNew_Lr14r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r5",
        "label": "Q9hNew_Lr14r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r6",
        "label": "Q9hNew_Lr14r6: Banner ads for Seattle Genetics you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r7",
        "label": "Q9hNew_Lr14r7: Social media page for Seattle Genetics (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r8",
        "label": "Q9hNew_Lr14r8: Ads for Seattle Genetics you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r9",
        "label": "Q9hNew_Lr14r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr14r98",
        "label": "Q9hNew_Lr14r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Seattle Genetics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr15",
    "questionText": "Q9hNew_Lr15",
    "items": [
      {
        "column": "Q9hNew_Lr15r1",
        "label": "Q9hNew_Lr15r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r2",
        "label": "Q9hNew_Lr15r2: Information you viewed on the GSK website - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r3",
        "label": "Q9hNew_Lr15r3: Information about GSK you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r4",
        "label": "Q9hNew_Lr15r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r5",
        "label": "Q9hNew_Lr15r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r6",
        "label": "Q9hNew_Lr15r6: Banner ads for GSK you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r7",
        "label": "Q9hNew_Lr15r7: Social media page for GSK (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r8",
        "label": "Q9hNew_Lr15r8: Ads for GSK you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r9",
        "label": "Q9hNew_Lr15r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr15r98",
        "label": "Q9hNew_Lr15r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for GSK related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr16",
    "questionText": "Q9hNew_Lr16",
    "items": [
      {
        "column": "Q9hNew_Lr16r1",
        "label": "Q9hNew_Lr16r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r2",
        "label": "Q9hNew_Lr16r2: Information you viewed on the AstraZeneca website - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r3",
        "label": "Q9hNew_Lr16r3: Information about AstraZeneca you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r4",
        "label": "Q9hNew_Lr16r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r5",
        "label": "Q9hNew_Lr16r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r6",
        "label": "Q9hNew_Lr16r6: Banner ads for AstraZeneca you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r7",
        "label": "Q9hNew_Lr16r7: Social media page for AstraZeneca (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r8",
        "label": "Q9hNew_Lr16r8: Ads for AstraZeneca you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r9",
        "label": "Q9hNew_Lr16r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr16r98",
        "label": "Q9hNew_Lr16r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for AstraZeneca related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9hNew_Lr17",
    "questionText": "Q9hNew_Lr17",
    "items": [
      {
        "column": "Q9hNew_Lr17r1",
        "label": "Q9hNew_Lr17r1: Informational email - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r2",
        "label": "Q9hNew_Lr17r2: Information you viewed on the Gilead / Immunomedics website - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r3",
        "label": "Q9hNew_Lr17r3: Information about Gilead / Immunomedics you received from or viewed on a governmental or association source (e.g., the FDA) - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r4",
        "label": "Q9hNew_Lr17r4: Medical journals / publications in print - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r5",
        "label": "Q9hNew_Lr17r5: Medical journals / publications online - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r6",
        "label": "Q9hNew_Lr17r6: Banner ads for Gilead / Immunomedics you viewed on a third party site (e.g., Medscape, Bulletin Healthcare) - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfo",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r7",
        "label": "Q9hNew_Lr17r7: Social media page for Gilead / Immunomedics (e.g., Facebook, Twitter) - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r8",
        "label": "Q9hNew_Lr17r8: Ads for Gilead / Immunomedics you viewed on a social media site (e.g., Facebook) - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r9",
        "label": "Q9hNew_Lr17r9: Virtual conference / trade show - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q9hNew_Lr17r98",
        "label": "Q9hNew_Lr17r98: Other (please specify) - In the past 6 months, where do you recall seeing or hearing advertising for Gilead / Immunomedics related to their oncology portfolio?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q9g",
    "questionText": "Q9g",
    "items": [
      {
        "column": "Q9gr1",
        "label": "Q9gr1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Earlier you rated your experience with the personnel you interact with most frequently related to oncology drugs from several companies on t",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          }
        ]
      },
      {
        "column": "Q9gr2",
        "label": "Q9gr2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Earlier you rated your experience with the personnel you interact with most frequently related to oncology drugs from several companie",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          }
        ]
      },
      {
        "column": "Q9gr3",
        "label": "Q9gr3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Earlier you rated your experience with the personnel you interact with most frequently related to oncology drugs from several companies o",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          }
        ]
      },
      {
        "column": "Q9gr4",
        "label": "Q9gr4: Other - Earlier you rated your experience with the personnel you interact with most frequently related to oncology drugs from several companies on the attribute of “Understands my practice.” In general, what is most important to you when thinki",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr1",
    "questionText": "Q9h_Lr1",
    "items": [
      {
        "column": "Q9h_Lr1r1",
        "label": "Q9h_Lr1r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the attr",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr1r2",
        "label": "Q9h_Lr1r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on th",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr1r3",
        "label": "Q9h_Lr1r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr1r4",
        "label": "Q9h_Lr1r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Astellas on the attributes relating to “Understanding your practice”.These can be reps, account managers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr2",
    "questionText": "Q9h_Lr2",
    "items": [
      {
        "column": "Q9h_Lr2r1",
        "label": "Q9h_Lr2r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono o",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr2r2",
        "label": "Q9h_Lr2r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Se",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr2r3",
        "label": "Q9h_Lr2r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Seron",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr2r4",
        "label": "Q9h_Lr2r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Merck / EMD Serono on the attributes relating to “Understanding your practice”.These can be reps, accoun",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr3",
    "questionText": "Q9h_Lr3",
    "items": [
      {
        "column": "Q9h_Lr3r1",
        "label": "Q9h_Lr3r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr3r2",
        "label": "Q9h_Lr3r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr3r3",
        "label": "Q9h_Lr3r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squ",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr3r4",
        "label": "Q9h_Lr3r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bristol-Myers Squibb (BMS) on the attributes relating to “Understanding your practice”.These can be reps",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr4",
    "questionText": "Q9h_Lr4",
    "items": [
      {
        "column": "Q9h_Lr4r1",
        "label": "Q9h_Lr4r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr4r2",
        "label": "Q9h_Lr4r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Ro",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr4r3",
        "label": "Q9h_Lr4r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr4r4",
        "label": "Q9h_Lr4r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Genentech / Roche on the attributes relating to “Understanding your practice”.These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr5",
    "questionText": "Q9h_Lr5",
    "items": [
      {
        "column": "Q9h_Lr5r1",
        "label": "Q9h_Lr5r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the attrib",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr5r2",
        "label": "Q9h_Lr5r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr5r3",
        "label": "Q9h_Lr5r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the att",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr5r4",
        "label": "Q9h_Lr5r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Pfizer on the attributes relating to “Understanding your practice”.These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr6",
    "questionText": "Q9h_Lr6",
    "items": [
      {
        "column": "Q9h_Lr6r1",
        "label": "Q9h_Lr6r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson &",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr6r2",
        "label": "Q9h_Lr6r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / John",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr6r3",
        "label": "Q9h_Lr6r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr6r4",
        "label": "Q9h_Lr6r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Janssen / Johnson & Johnson on the attributes relating to “Understanding your practice”.These can be rep",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr7",
    "questionText": "Q9h_Lr7",
    "items": [
      {
        "column": "Q9h_Lr7r1",
        "label": "Q9h_Lr7r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the attribu",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr7r2",
        "label": "Q9h_Lr7r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr7r3",
        "label": "Q9h_Lr7r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the attr",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr7r4",
        "label": "Q9h_Lr7r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Bayer on the attributes relating to “Understanding your practice”.These can be reps, account managers, M",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr8",
    "questionText": "Q9h_Lr8",
    "items": [
      {
        "column": "Q9h_Lr8r1",
        "label": "Q9h_Lr8r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the attrib",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr8r2",
        "label": "Q9h_Lr8r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr8r3",
        "label": "Q9h_Lr8r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the att",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr8r4",
        "label": "Q9h_Lr8r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Abbvie on the attributes relating to “Understanding your practice”.These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr9",
    "questionText": "Q9h_Lr9",
    "items": [
      {
        "column": "Q9h_Lr9r1",
        "label": "Q9h_Lr9r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the attrib",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr9r2",
        "label": "Q9h_Lr9r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr9r3",
        "label": "Q9h_Lr9r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the att",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr9r4",
        "label": "Q9h_Lr9r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Sanofi on the attributes relating to “Understanding your practice”.These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr10",
    "questionText": "Q9h_Lr10",
    "items": [
      {
        "column": "Q9h_Lr10r1",
        "label": "Q9h_Lr10r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the attrib",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr10r2",
        "label": "Q9h_Lr10r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr10r3",
        "label": "Q9h_Lr10r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the att",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr10r4",
        "label": "Q9h_Lr10r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Lilly on the attributes relating to “Understanding your practice”.These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr11",
    "questionText": "Q9h_Lr11",
    "items": [
      {
        "column": "Q9h_Lr11r1",
        "label": "Q9h_Lr11r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the att",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr11r2",
        "label": "Q9h_Lr11r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on t",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr11r3",
        "label": "Q9h_Lr11r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr11r4",
        "label": "Q9h_Lr11r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Novartis on the attributes relating to “Understanding your practice”.These can be reps, account manager",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr12",
    "questionText": "Q9h_Lr12",
    "items": [
      {
        "column": "Q9h_Lr12r1",
        "label": "Q9h_Lr12r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on t",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr12r2",
        "label": "Q9h_Lr12r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sanky",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr12r3",
        "label": "Q9h_Lr12r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo o",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr12r4",
        "label": "Q9h_Lr12r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Daiichi-Sankyo on the attributes relating to “Understanding your practice”.These can be reps, account m",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr13",
    "questionText": "Q9h_Lr13",
    "items": [
      {
        "column": "Q9h_Lr13r1",
        "label": "Q9h_Lr13r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the attrib",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr13r2",
        "label": "Q9h_Lr13r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr13r3",
        "label": "Q9h_Lr13r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the att",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr13r4",
        "label": "Q9h_Lr13r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Amgen on the attributes relating to “Understanding your practice”.These can be reps, account managers,",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr14",
    "questionText": "Q9h_Lr14",
    "items": [
      {
        "column": "Q9h_Lr14r1",
        "label": "Q9h_Lr14r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr14r2",
        "label": "Q9h_Lr14r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genet",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr14r3",
        "label": "Q9h_Lr14r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr14r4",
        "label": "Q9h_Lr14r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Seattle Genetics on the attributes relating to “Understanding your practice”.These can be reps, account",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr15",
    "questionText": "Q9h_Lr15",
    "items": [
      {
        "column": "Q9h_Lr15r1",
        "label": "Q9h_Lr15r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the attribut",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr15r2",
        "label": "Q9h_Lr15r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the at",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr15r3",
        "label": "Q9h_Lr15r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the attri",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr15r4",
        "label": "Q9h_Lr15r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from GSK on the attributes relating to “Understanding your practice”.These can be reps, account managers, MS",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr16",
    "questionText": "Q9h_Lr16",
    "items": [
      {
        "column": "Q9h_Lr16r1",
        "label": "Q9h_Lr16r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr16r2",
        "label": "Q9h_Lr16r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca o",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr16r3",
        "label": "Q9h_Lr16r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on t",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr16r4",
        "label": "Q9h_Lr16r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from AstraZeneca on the attributes relating to “Understanding your practice”.These can be reps, account mana",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q9h_Lr17",
    "questionText": "Q9h_Lr17",
    "items": [
      {
        "column": "Q9h_Lr17r1",
        "label": "Q9h_Lr17r1: Understands our practice’s interests (e.g. provides information based on what would be valuable for us) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedi",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr17r2",
        "label": "Q9h_Lr17r2: Understands our practice’s patient population (e.g. understands which drugs are relevant, our coverage needs) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immu",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr17r3",
        "label": "Q9h_Lr17r3: Understands our practice’s logistics/preferences (e.g. understands who to speak to, when/how to reach out) - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunom",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      },
      {
        "column": "Q9h_Lr17r4",
        "label": "Q9h_Lr17r4: $ {Q9G_OE.r1.val} - Now please rate your experience with the personnel you interact with most frequently related to oncology drugs from Gilead / Immunomedics on the attributes relating to “Understanding your practice”.These can be reps, ac",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Does Not Describe at all1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Describes Completely 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q10_AML",
    "questionText": "Q10_AML",
    "items": [
      {
        "column": "Q10_AMLr1",
        "label": "Q10_AMLr1: Xospata (gilteritinib) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr2",
        "label": "Q10_AMLr2: RYDAPT (midostaurin) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr3",
        "label": "Q10_AMLr3: Mylotarg (gemtuzumab ozogamicin) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr4",
        "label": "Q10_AMLr4: Tibsovo (Ivosidenib) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr5",
        "label": "Q10_AMLr5: Idhifa (enasidenib) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr6",
        "label": "Q10_AMLr6: Daurismo (glasdegib) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr7",
        "label": "Q10_AMLr7: Venclexta (venetoclax) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr8",
        "label": "Q10_AMLr8: Nexavar (sorafenib) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr9",
        "label": "Q10_AMLr9: VYXEOS (daunorubicin - cytarabine) - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_AMLr10",
        "label": "Q10_AMLr10: None of the above - For your acute myeloid leukemia (AML) patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr1",
    "questionText": "Q11_AML_Lr1",
    "items": [
      {
        "column": "Q11_AML_Lr1r1",
        "label": "Q11_AML_Lr1r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr1r2",
        "label": "Q11_AML_Lr1r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr1r3",
        "label": "Q11_AML_Lr1r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr1r4",
        "label": "Q11_AML_Lr1r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr2",
    "questionText": "Q11_AML_Lr2",
    "items": [
      {
        "column": "Q11_AML_Lr2r1",
        "label": "Q11_AML_Lr2r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr2r2",
        "label": "Q11_AML_Lr2r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr2r3",
        "label": "Q11_AML_Lr2r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr2r4",
        "label": "Q11_AML_Lr2r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr3",
    "questionText": "Q11_AML_Lr3",
    "items": [
      {
        "column": "Q11_AML_Lr3r1",
        "label": "Q11_AML_Lr3r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr3r2",
        "label": "Q11_AML_Lr3r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr3r3",
        "label": "Q11_AML_Lr3r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr3r4",
        "label": "Q11_AML_Lr3r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr4",
    "questionText": "Q11_AML_Lr4",
    "items": [
      {
        "column": "Q11_AML_Lr4r1",
        "label": "Q11_AML_Lr4r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr4r2",
        "label": "Q11_AML_Lr4r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr4r3",
        "label": "Q11_AML_Lr4r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr4r4",
        "label": "Q11_AML_Lr4r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr5",
    "questionText": "Q11_AML_Lr5",
    "items": [
      {
        "column": "Q11_AML_Lr5r1",
        "label": "Q11_AML_Lr5r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr5r2",
        "label": "Q11_AML_Lr5r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr5r3",
        "label": "Q11_AML_Lr5r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr5r4",
        "label": "Q11_AML_Lr5r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr6",
    "questionText": "Q11_AML_Lr6",
    "items": [
      {
        "column": "Q11_AML_Lr6r1",
        "label": "Q11_AML_Lr6r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr6r2",
        "label": "Q11_AML_Lr6r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr6r3",
        "label": "Q11_AML_Lr6r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr6r4",
        "label": "Q11_AML_Lr6r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr7",
    "questionText": "Q11_AML_Lr7",
    "items": [
      {
        "column": "Q11_AML_Lr7r1",
        "label": "Q11_AML_Lr7r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr7r2",
        "label": "Q11_AML_Lr7r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr7r3",
        "label": "Q11_AML_Lr7r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr7r4",
        "label": "Q11_AML_Lr7r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr8",
    "questionText": "Q11_AML_Lr8",
    "items": [
      {
        "column": "Q11_AML_Lr8r1",
        "label": "Q11_AML_Lr8r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr8r2",
        "label": "Q11_AML_Lr8r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr8r3",
        "label": "Q11_AML_Lr8r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr8r4",
        "label": "Q11_AML_Lr8r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr9",
    "questionText": "Q11_AML_Lr9",
    "items": [
      {
        "column": "Q11_AML_Lr9r1",
        "label": "Q11_AML_Lr9r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr9r2",
        "label": "Q11_AML_Lr9r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr9r3",
        "label": "Q11_AML_Lr9r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr9r4",
        "label": "Q11_AML_Lr9r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_AML_Lr10",
    "questionText": "Q11_AML_Lr10",
    "items": [
      {
        "column": "Q11_AML_Lr10r1",
        "label": "Q11_AML_Lr10r1: Overall experience prescribing drug - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr10r2",
        "label": "Q11_AML_Lr10r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr10r3",
        "label": "Q11_AML_Lr10r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_AML_Lr10r4",
        "label": "Q11_AML_Lr10r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q12_AML",
    "questionText": "Q12_AML",
    "items": [
      {
        "column": "Q12_AMLc1",
        "label": "Q12_AMLc1: Xospata (Gilteritinib) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc2",
        "label": "Q12_AMLc2: RYDAPT (midostaurin) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc3",
        "label": "Q12_AMLc3: Mylotarg (gemtuzumab ozogamicin) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc4",
        "label": "Q12_AMLc4: Tibsovo (Ivosidenib) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc5",
        "label": "Q12_AMLc5: Idhifa (enasidenib) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc6",
        "label": "Q12_AMLc6: Daurismo (glasdegib) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc7",
        "label": "Q12_AMLc7: Venclexta (venetoclax) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc8",
        "label": "Q12_AMLc8: Nexavar (sorafenib) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc9",
        "label": "Q12_AMLc9: VYXEOS (daunorubicin - cytarabine) - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc10",
        "label": "Q12_AMLc10: $ {Q10_AML.r10.open} - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_AMLc11",
        "label": "Q12_AMLc11: None of the above - How do you expect your prescribing of each of the following AML treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q10a_AML",
    "questionText": "Q10a_AML",
    "items": [
      {
        "column": "Q10a_AMLr1",
        "label": "Q10a_AMLr1: Xospata (gilteritinib) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr2",
        "label": "Q10a_AMLr2: RYDAPT (midostaurin) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr3",
        "label": "Q10a_AMLr3: Mylotarg (gemtuzumab ozogamicin) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr4",
        "label": "Q10a_AMLr4: Tibsovo (Ivosidenib) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr5",
        "label": "Q10a_AMLr5: Idhifa (enasidenib) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr6",
        "label": "Q10a_AMLr6: Daurismo (glasdegib) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr7",
        "label": "Q10a_AMLr7: Venclexta (venetoclax) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr8",
        "label": "Q10a_AMLr8: Nexavar (sorafenib) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr9",
        "label": "Q10a_AMLr9: VYXEOS (daunorubicin - cytarabine) - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr10",
        "label": "Q10a_AMLr10: Other, please specify: - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_AMLr11",
        "label": "Q10a_AMLr11: None of the above - Which of the following medications were prescribed for the acute myeloid leukemia (AML) patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr1",
    "questionText": "Q11a_AML_Lr1",
    "items": [
      {
        "column": "Q11a_AML_Lr1r1",
        "label": "Q11a_AML_Lr1r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr1r2",
        "label": "Q11a_AML_Lr1r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr1r3",
        "label": "Q11a_AML_Lr1r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr1r4",
        "label": "Q11a_AML_Lr1r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Xospata (gilteritinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr2",
    "questionText": "Q11a_AML_Lr2",
    "items": [
      {
        "column": "Q11a_AML_Lr2r1",
        "label": "Q11a_AML_Lr2r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr2r2",
        "label": "Q11a_AML_Lr2r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr2r3",
        "label": "Q11a_AML_Lr2r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr2r4",
        "label": "Q11a_AML_Lr2r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: RYDAPT (midostaurin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr3",
    "questionText": "Q11a_AML_Lr3",
    "items": [
      {
        "column": "Q11a_AML_Lr3r1",
        "label": "Q11a_AML_Lr3r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr3r2",
        "label": "Q11a_AML_Lr3r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr3r3",
        "label": "Q11a_AML_Lr3r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr3r4",
        "label": "Q11a_AML_Lr3r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Mylotarg (gemtuzumab ozogamicin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr4",
    "questionText": "Q11a_AML_Lr4",
    "items": [
      {
        "column": "Q11a_AML_Lr4r1",
        "label": "Q11a_AML_Lr4r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr4r2",
        "label": "Q11a_AML_Lr4r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr4r3",
        "label": "Q11a_AML_Lr4r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr4r4",
        "label": "Q11a_AML_Lr4r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Tibsovo (Ivosidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr5",
    "questionText": "Q11a_AML_Lr5",
    "items": [
      {
        "column": "Q11a_AML_Lr5r1",
        "label": "Q11a_AML_Lr5r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr5r2",
        "label": "Q11a_AML_Lr5r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr5r3",
        "label": "Q11a_AML_Lr5r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr5r4",
        "label": "Q11a_AML_Lr5r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Idhifa (enasidenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr6",
    "questionText": "Q11a_AML_Lr6",
    "items": [
      {
        "column": "Q11a_AML_Lr6r1",
        "label": "Q11a_AML_Lr6r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr6r2",
        "label": "Q11a_AML_Lr6r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr6r3",
        "label": "Q11a_AML_Lr6r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr6r4",
        "label": "Q11a_AML_Lr6r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Daurismo (glasdegib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr7",
    "questionText": "Q11a_AML_Lr7",
    "items": [
      {
        "column": "Q11a_AML_Lr7r1",
        "label": "Q11a_AML_Lr7r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr7r2",
        "label": "Q11a_AML_Lr7r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr7r3",
        "label": "Q11a_AML_Lr7r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr7r4",
        "label": "Q11a_AML_Lr7r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Venclexta (venetoclax)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr8",
    "questionText": "Q11a_AML_Lr8",
    "items": [
      {
        "column": "Q11a_AML_Lr8r1",
        "label": "Q11a_AML_Lr8r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr8r2",
        "label": "Q11a_AML_Lr8r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr8r3",
        "label": "Q11a_AML_Lr8r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr8r4",
        "label": "Q11a_AML_Lr8r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: Nexavar (sorafenib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr9",
    "questionText": "Q11a_AML_Lr9",
    "items": [
      {
        "column": "Q11a_AML_Lr9r1",
        "label": "Q11a_AML_Lr9r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr9r2",
        "label": "Q11a_AML_Lr9r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr9r3",
        "label": "Q11a_AML_Lr9r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr9r4",
        "label": "Q11a_AML_Lr9r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes: VYXEOS (daunorubicin - cytarabine)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_AML_Lr10",
    "questionText": "Q11a_AML_Lr10",
    "items": [
      {
        "column": "Q11a_AML_Lr10r1",
        "label": "Q11a_AML_Lr10r1: Overall experience with the drug - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr10r2",
        "label": "Q11a_AML_Lr10r2: Ease of access - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr10r3",
        "label": "Q11a_AML_Lr10r3: Availability of financial support from manufacturer - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_AML_Lr10r4",
        "label": "Q11a_AML_Lr10r4: Experience with drug rep - Please rate your experience with each of the following AML treatment(s) on the following attributes:",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q10_PC",
    "questionText": "Q10_PC",
    "items": [
      {
        "column": "Q10_PCr1",
        "label": "Q10_PCr1: Xtandi (enzalutamide) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr2",
        "label": "Q10_PCr2: Provenge (sipuleucel-T) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr3",
        "label": "Q10_PCr3: Xofigo (radium RA 223 dichloride) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr4",
        "label": "Q10_PCr4: Casodex (bicalutamide) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr5",
        "label": "Q10_PCr5: Branded Zytiga (abiraterone acetate) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr6",
        "label": "Q10_PCr6: Erleada (apalutamide) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr8",
        "label": "Q10_PCr8: Nubeqa (darolutamide) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr10",
        "label": "Q10_PCr10: Generic abiraterone acetate - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr9",
        "label": "Q10_PCr9: ORGOVYX (relugolix) - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_PCr7",
        "label": "Q10_PCr7: None of the above - For your non-curative prostate cancer patients, which of the following medications have you personally prescribed in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Prog_Q11_PC_Loop_Order",
    "questionText": "Prog_Q11_PC_Loop_Order",
    "items": [
      {
        "column": "Prog_Q11_PC_Loop_Orderr1",
        "label": "Prog_Q11_PC_Loop_Orderr1: Xtandi (enzalutamide) - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ]
      },
      {
        "column": "Prog_Q11_PC_Loop_Orderr2",
        "label": "Prog_Q11_PC_Loop_Orderr2: Provenge (sipuleucel-T) - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: [object Object]-[object Object]",
        "rangeMin": {},
        "rangeMax": {}
      },
      {
        "column": "Prog_Q11_PC_Loop_Orderr3",
        "label": "Prog_Q11_PC_Loop_Orderr3: Xofigo (radium RA 223 dichloride) - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: [object Object]-[object Object]",
        "rangeMin": {},
        "rangeMax": {}
      },
      {
        "column": "Prog_Q11_PC_Loop_Orderr4",
        "label": "Prog_Q11_PC_Loop_Orderr4: Casodex (bicalutamide) - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: [object Object]-[object Object]",
        "rangeMin": {},
        "rangeMax": {}
      },
      {
        "column": "Prog_Q11_PC_Loop_Orderr5",
        "label": "Prog_Q11_PC_Loop_Orderr5: Branded Zytiga (abiraterone acetate) - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 2-4",
        "rangeMin": 2,
        "rangeMax": 4,
        "allowedValues": [
          2,
          3,
          4
        ]
      },
      {
        "column": "Prog_Q11_PC_Loop_Orderr6",
        "label": "Prog_Q11_PC_Loop_Orderr6: Erleada (apalutamide) - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ]
      },
      {
        "column": "Prog_Q11_PC_Loop_Orderr7",
        "label": "Prog_Q11_PC_Loop_Orderr7: Nubeqa (darolutamide) - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ]
      },
      {
        "column": "Prog_Q11_PC_Loop_Orderr8",
        "label": "Prog_Q11_PC_Loop_Orderr8: None of the above - Hidden Question - For Loop Order",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: [object Object]-[object Object]",
        "rangeMin": {},
        "rangeMax": {}
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr1",
    "questionText": "Q11_PC_Lr1",
    "items": [
      {
        "column": "Q11_PC_Lr1r1",
        "label": "Q11_PC_Lr1r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr1r2",
        "label": "Q11_PC_Lr1r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr1r3",
        "label": "Q11_PC_Lr1r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr1r4",
        "label": "Q11_PC_Lr1r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr2",
    "questionText": "Q11_PC_Lr2",
    "items": [
      {
        "column": "Q11_PC_Lr2r1",
        "label": "Q11_PC_Lr2r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr2r2",
        "label": "Q11_PC_Lr2r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr2r3",
        "label": "Q11_PC_Lr2r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr2r4",
        "label": "Q11_PC_Lr2r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr3",
    "questionText": "Q11_PC_Lr3",
    "items": [
      {
        "column": "Q11_PC_Lr3r1",
        "label": "Q11_PC_Lr3r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr3r2",
        "label": "Q11_PC_Lr3r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr3r3",
        "label": "Q11_PC_Lr3r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr3r4",
        "label": "Q11_PC_Lr3r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr4",
    "questionText": "Q11_PC_Lr4",
    "items": [
      {
        "column": "Q11_PC_Lr4r1",
        "label": "Q11_PC_Lr4r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr4r2",
        "label": "Q11_PC_Lr4r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr4r3",
        "label": "Q11_PC_Lr4r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr4r4",
        "label": "Q11_PC_Lr4r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr5",
    "questionText": "Q11_PC_Lr5",
    "items": [
      {
        "column": "Q11_PC_Lr5r1",
        "label": "Q11_PC_Lr5r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr5r2",
        "label": "Q11_PC_Lr5r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr5r3",
        "label": "Q11_PC_Lr5r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr5r4",
        "label": "Q11_PC_Lr5r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr6",
    "questionText": "Q11_PC_Lr6",
    "items": [
      {
        "column": "Q11_PC_Lr6r1",
        "label": "Q11_PC_Lr6r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr6r2",
        "label": "Q11_PC_Lr6r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr6r3",
        "label": "Q11_PC_Lr6r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr6r4",
        "label": "Q11_PC_Lr6r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr7",
    "questionText": "Q11_PC_Lr7",
    "items": [
      {
        "column": "Q11_PC_Lr7r1",
        "label": "Q11_PC_Lr7r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr7r2",
        "label": "Q11_PC_Lr7r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr7r3",
        "label": "Q11_PC_Lr7r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr7r4",
        "label": "Q11_PC_Lr7r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_PC_Lr8",
    "questionText": "Q11_PC_Lr8",
    "items": [
      {
        "column": "Q11_PC_Lr8r1",
        "label": "Q11_PC_Lr8r1: Overall experience prescribing drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr8r2",
        "label": "Q11_PC_Lr8r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr8r3",
        "label": "Q11_PC_Lr8r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      },
      {
        "column": "Q11_PC_Lr8r4",
        "label": "Q11_PC_Lr8r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q12_PC",
    "questionText": "Q12_PC",
    "items": [
      {
        "column": "Q12_PCc1",
        "label": "Q12_PCc1: Xtandi (enzalutamide) - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_PCc2",
        "label": "Q12_PCc2: Provenge (sipuleucel-T) - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_PCc3",
        "label": "Q12_PCc3: Xofigo (radium RA 223 dichloride) - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_PCc4",
        "label": "Q12_PCc4: Casodex (bicalutamide) - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_PCc5",
        "label": "Q12_PCc5: Branded Zytiga (abiraterone acetate) - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_PCc6",
        "label": "Q12_PCc6: ERLEADA (apalutamide) - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_PCc7",
        "label": "Q12_PCc7: NUBEQA(darolutamide) - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_PCc8",
        "label": "Q12_PCc8: None of the above - How do you expect your prescribing of each of the following non-curative prostate cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q10a_PC",
    "questionText": "Q10a_PC",
    "items": [
      {
        "column": "Q10a_PCr1",
        "label": "Q10a_PCr1: Xtandi (enzalutamide) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr2",
        "label": "Q10a_PCr2: Provenge (sipuleucel-T) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr3",
        "label": "Q10a_PCr3: Xofigo (radium RA 223 dichloride) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr4",
        "label": "Q10a_PCr4: Casodex (bicalutamide) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr5",
        "label": "Q10a_PCr5: Branded Zytiga (abiraterone acetate) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr6",
        "label": "Q10a_PCr6: Erleada (apalutamide) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr8",
        "label": "Q10a_PCr8: Nubeqa (darolutamide) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr10",
        "label": "Q10a_PCr10: Generic abiraterone acetate - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr9",
        "label": "Q10a_PCr9: ORGOVYX (relugolix) - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_PCr7",
        "label": "Q10a_PCr7: None of the above - Which of the following medications were prescribed for the non-curative prostate cancer patients treated in your practice in the last 6 months (include both new and refill prescriptions)?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr1",
    "questionText": "Q11a_PC_Lr1",
    "items": [
      {
        "column": "Q11a_PC_Lr1r1",
        "label": "Q11a_PC_Lr1r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr1r2",
        "label": "Q11a_PC_Lr1r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr1r3",
        "label": "Q11a_PC_Lr1r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr1r4",
        "label": "Q11a_PC_Lr1r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xtandi (enzalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr2",
    "questionText": "Q11a_PC_Lr2",
    "items": [
      {
        "column": "Q11a_PC_Lr2r1",
        "label": "Q11a_PC_Lr2r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr2r2",
        "label": "Q11a_PC_Lr2r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr2r3",
        "label": "Q11a_PC_Lr2r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr2r4",
        "label": "Q11a_PC_Lr2r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Provenge (sipuleucel-T)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr3",
    "questionText": "Q11a_PC_Lr3",
    "items": [
      {
        "column": "Q11a_PC_Lr3r1",
        "label": "Q11a_PC_Lr3r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr3r2",
        "label": "Q11a_PC_Lr3r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr3r3",
        "label": "Q11a_PC_Lr3r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr3r4",
        "label": "Q11a_PC_Lr3r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Xofigo (radium RA 223 dichloride)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr4",
    "questionText": "Q11a_PC_Lr4",
    "items": [
      {
        "column": "Q11a_PC_Lr4r1",
        "label": "Q11a_PC_Lr4r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr4r2",
        "label": "Q11a_PC_Lr4r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr4r3",
        "label": "Q11a_PC_Lr4r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr4r4",
        "label": "Q11a_PC_Lr4r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Casodex (bicalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr5",
    "questionText": "Q11a_PC_Lr5",
    "items": [
      {
        "column": "Q11a_PC_Lr5r1",
        "label": "Q11a_PC_Lr5r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr5r2",
        "label": "Q11a_PC_Lr5r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr5r3",
        "label": "Q11a_PC_Lr5r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr5r4",
        "label": "Q11a_PC_Lr5r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Branded Zytiga (abiraterone acetate)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr6",
    "questionText": "Q11a_PC_Lr6",
    "items": [
      {
        "column": "Q11a_PC_Lr6r1",
        "label": "Q11a_PC_Lr6r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr6r2",
        "label": "Q11a_PC_Lr6r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr6r3",
        "label": "Q11a_PC_Lr6r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr6r4",
        "label": "Q11a_PC_Lr6r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Erleada (apalutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr7",
    "questionText": "Q11a_PC_Lr7",
    "items": [
      {
        "column": "Q11a_PC_Lr7r1",
        "label": "Q11a_PC_Lr7r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr7r2",
        "label": "Q11a_PC_Lr7r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr7r3",
        "label": "Q11a_PC_Lr7r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr7r4",
        "label": "Q11a_PC_Lr7r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: Nubeqa (darolutamide)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_PC_Lr8",
    "questionText": "Q11a_PC_Lr8",
    "items": [
      {
        "column": "Q11a_PC_Lr8r1",
        "label": "Q11a_PC_Lr8r1: Overall experience with the drug - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr8r2",
        "label": "Q11a_PC_Lr8r2: Ease of access - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr8r3",
        "label": "Q11a_PC_Lr8r3: Availability of financial support from manufacturer - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_PC_Lr8r4",
        "label": "Q11a_PC_Lr8r4: Experience with drug rep - Please rate your experience with each of the following non-curative prostate cancer treatments on the following attributes: None of the above",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q10_BC",
    "questionText": "Q10_BC",
    "items": [
      {
        "column": "Q10_BCr1",
        "label": "Q10_BCr1: PADCEV (enfortumab vedotin) - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_BCr2",
        "label": "Q10_BCr2: Balversa (erdafitinib) - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_BCr3",
        "label": "Q10_BCr3: Tecentriq (atezolizumab) - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_BCr4",
        "label": "Q10_BCr4: Keytruda (pembrolizumab) - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_BCr5",
        "label": "Q10_BCr5: Opdivo (nivolumab) - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_BCr7",
        "label": "Q10_BCr7: Trodelvy (sacituzumab govitecan) - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_BCr8",
        "label": "Q10_BCr8: Bavencio (avelumab) - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10_BCr6",
        "label": "Q10_BCr6: None of the above - For your bladder cancer patients, which of the following medications have you personally prescribed in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q11_BC_Lr1",
    "questionText": "Q11_BC_Lr1",
    "items": [
      {
        "column": "Q11_BC_Lr1r1",
        "label": "Q11_BC_Lr1r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr1r2",
        "label": "Q11_BC_Lr1r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr1r3",
        "label": "Q11_BC_Lr1r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr1r4",
        "label": "Q11_BC_Lr1r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_BC_Lr2",
    "questionText": "Q11_BC_Lr2",
    "items": [
      {
        "column": "Q11_BC_Lr2r1",
        "label": "Q11_BC_Lr2r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr2r2",
        "label": "Q11_BC_Lr2r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr2r3",
        "label": "Q11_BC_Lr2r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr2r4",
        "label": "Q11_BC_Lr2r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_BC_Lr3",
    "questionText": "Q11_BC_Lr3",
    "items": [
      {
        "column": "Q11_BC_Lr3r1",
        "label": "Q11_BC_Lr3r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr3r2",
        "label": "Q11_BC_Lr3r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr3r3",
        "label": "Q11_BC_Lr3r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr3r4",
        "label": "Q11_BC_Lr3r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_BC_Lr4",
    "questionText": "Q11_BC_Lr4",
    "items": [
      {
        "column": "Q11_BC_Lr4r1",
        "label": "Q11_BC_Lr4r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr4r2",
        "label": "Q11_BC_Lr4r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr4r3",
        "label": "Q11_BC_Lr4r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr4r4",
        "label": "Q11_BC_Lr4r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_BC_Lr5",
    "questionText": "Q11_BC_Lr5",
    "items": [
      {
        "column": "Q11_BC_Lr5r1",
        "label": "Q11_BC_Lr5r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr5r2",
        "label": "Q11_BC_Lr5r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr5r3",
        "label": "Q11_BC_Lr5r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr5r4",
        "label": "Q11_BC_Lr5r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_BC_Lr7",
    "questionText": "Q11_BC_Lr7",
    "items": [
      {
        "column": "Q11_BC_Lr7r1",
        "label": "Q11_BC_Lr7r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr7r2",
        "label": "Q11_BC_Lr7r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr7r3",
        "label": "Q11_BC_Lr7r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr7r4",
        "label": "Q11_BC_Lr7r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11_BC_Lr8",
    "questionText": "Q11_BC_Lr8",
    "items": [
      {
        "column": "Q11_BC_Lr8r1",
        "label": "Q11_BC_Lr8r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr8r2",
        "label": "Q11_BC_Lr8r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr8r3",
        "label": "Q11_BC_Lr8r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      },
      {
        "column": "Q11_BC_Lr8r4",
        "label": "Q11_BC_Lr8r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q12_BC",
    "questionText": "Q12_BC",
    "items": [
      {
        "column": "Q12_BCc1",
        "label": "Q12_BCc1: PADCEV (enfortumab vedotin) - How do you expect your prescribing of each of the following bladder cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_BCc2",
        "label": "Q12_BCc2: Balversa (erdafitinib) - How do you expect your prescribing of each of the following bladder cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_BCc3",
        "label": "Q12_BCc3: Tecentriq (atezolizumab) - How do you expect your prescribing of each of the following bladder cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_BCc4",
        "label": "Q12_BCc4: Keytruda (pembrolizumab) - How do you expect your prescribing of each of the following bladder cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_BCc5",
        "label": "Q12_BCc5: Opdivo (nivolumab) - How do you expect your prescribing of each of the following bladder cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_BCc7",
        "label": "Q12_BCc7: Trodelvy (sacituzumab govitecan) - How do you expect your prescribing of each of the following bladder cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      },
      {
        "column": "Q12_BCc8",
        "label": "Q12_BCc8: Bavencio (avelumab) - How do you expect your prescribing of each of the following bladder cancer treatment(s) will change in the next year?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Prescribe more"
          },
          {
            "value": 2,
            "label": "Prescribe less"
          },
          {
            "value": 3,
            "label": "Prescribe about the same"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q10a_BC",
    "questionText": "Q10a_BC",
    "items": [
      {
        "column": "Q10a_BCr1",
        "label": "Q10a_BCr1: PADCEV (enfortumab vedotin) - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_BCr2",
        "label": "Q10a_BCr2: Balversa (erdafitinib) - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_BCr3",
        "label": "Q10a_BCr3: Tecentriq (atezolizumab) - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_BCr4",
        "label": "Q10a_BCr4: Keytruda (pembrolizumab) - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_BCr5",
        "label": "Q10a_BCr5: Opdivo (nivolumab) - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_BCr7",
        "label": "Q10a_BCr7: Trodelvy (sacituzumab govitecan) - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_BCr8",
        "label": "Q10a_BCr8: Bavencio (avelumab) - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      },
      {
        "column": "Q10a_BCr6",
        "label": "Q10a_BCr6: None of the above - Which of the following medications were prescribed for the bladder cancer patients treated in your practice in the last 6 months?",
        "context": "",
        "normalizedType": "binary_flag",
        "valueType": "Values: 0-1",
        "rangeMin": 0,
        "rangeMax": 1,
        "allowedValues": [
          0,
          1
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_BC_Lr1",
    "questionText": "Q11a_BC_Lr1",
    "items": [
      {
        "column": "Q11a_BC_Lr1r1",
        "label": "Q11a_BC_Lr1r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr1r2",
        "label": "Q11a_BC_Lr1r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr1r3",
        "label": "Q11a_BC_Lr1r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr1r4",
        "label": "Q11a_BC_Lr1r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:PADCEV (enfortumab vedotin)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_BC_Lr2",
    "questionText": "Q11a_BC_Lr2",
    "items": [
      {
        "column": "Q11a_BC_Lr2r1",
        "label": "Q11a_BC_Lr2r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr2r2",
        "label": "Q11a_BC_Lr2r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr2r3",
        "label": "Q11a_BC_Lr2r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr2r4",
        "label": "Q11a_BC_Lr2r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Balversa (erdafitinib)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_BC_Lr3",
    "questionText": "Q11a_BC_Lr3",
    "items": [
      {
        "column": "Q11a_BC_Lr3r1",
        "label": "Q11a_BC_Lr3r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr3r2",
        "label": "Q11a_BC_Lr3r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr3r3",
        "label": "Q11a_BC_Lr3r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr3r4",
        "label": "Q11a_BC_Lr3r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Tecentriq (atezolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_BC_Lr4",
    "questionText": "Q11a_BC_Lr4",
    "items": [
      {
        "column": "Q11a_BC_Lr4r1",
        "label": "Q11a_BC_Lr4r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr4r2",
        "label": "Q11a_BC_Lr4r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr4r3",
        "label": "Q11a_BC_Lr4r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr4r4",
        "label": "Q11a_BC_Lr4r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Keytruda (pembrolizumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_BC_Lr5",
    "questionText": "Q11a_BC_Lr5",
    "items": [
      {
        "column": "Q11a_BC_Lr5r1",
        "label": "Q11a_BC_Lr5r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr5r2",
        "label": "Q11a_BC_Lr5r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr5r3",
        "label": "Q11a_BC_Lr5r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr5r4",
        "label": "Q11a_BC_Lr5r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Opdivo (nivolumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_BC_Lr7",
    "questionText": "Q11a_BC_Lr7",
    "items": [
      {
        "column": "Q11a_BC_Lr7r1",
        "label": "Q11a_BC_Lr7r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr7r2",
        "label": "Q11a_BC_Lr7r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr7r3",
        "label": "Q11a_BC_Lr7r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr7r4",
        "label": "Q11a_BC_Lr7r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Trodelvy (sacituzumab govitecan)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q11a_BC_Lr8",
    "questionText": "Q11a_BC_Lr8",
    "items": [
      {
        "column": "Q11a_BC_Lr8r1",
        "label": "Q11a_BC_Lr8r1: Overall experience prescribing drug - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr8r2",
        "label": "Q11a_BC_Lr8r2: Ease of access - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr8r3",
        "label": "Q11a_BC_Lr8r3: Availability of financial support from manufacturer - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      },
      {
        "column": "Q11a_BC_Lr8r4",
        "label": "Q11a_BC_Lr8r4: Experience with drug rep - Please rate your experience with each of the following bladder cancer treatments on the following attributes:Bavencio (avelumab)",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Not at all Satisfied1"
          },
          {
            "value": 2,
            "label": "2"
          },
          {
            "value": 3,
            "label": "3"
          },
          {
            "value": 4,
            "label": "4"
          },
          {
            "value": 5,
            "label": "5"
          },
          {
            "value": 6,
            "label": "6"
          },
          {
            "value": 7,
            "label": "7"
          },
          {
            "value": 8,
            "label": "8"
          },
          {
            "value": 9,
            "label": "9"
          },
          {
            "value": 10,
            "label": "Extremely Satisfied 10"
          },
          {
            "value": 11,
            "label": "Don’t Know / N/A"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q13",
    "questionText": "Q13",
    "items": [
      {
        "column": "Q13r1c1",
        "label": "Q13r1c1: Commercial Insurance (i.e. HMO/PPO) - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-70",
        "rangeMin": 0,
        "rangeMax": 70
      },
      {
        "column": "Q13r2c1",
        "label": "Q13r2c1: Medicare - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 0-80",
        "rangeMin": 0,
        "rangeMax": 80
      },
      {
        "column": "Q13r3c1",
        "label": "Q13r3c1: Medicaid - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 0-40",
        "rangeMin": 0,
        "rangeMax": 40,
        "allowedValues": [
          0,
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30,
          31,
          32,
          33,
          34,
          35,
          36,
          37,
          38,
          39,
          40
        ]
      },
      {
        "column": "Q13r4c1",
        "label": "Q13r4c1: VA/DoD - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 0-20",
        "rangeMin": 0,
        "rangeMax": 20,
        "allowedValues": [
          0,
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20
        ]
      },
      {
        "column": "Q13r5c1",
        "label": "Q13r5c1: Uninsured - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 0-30",
        "rangeMin": 0,
        "rangeMax": 30,
        "allowedValues": [
          0,
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30
        ]
      },
      {
        "column": "Q13r6c1",
        "label": "Q13r6c1: Other - We have just one final question for classification purposes. What is the distribution of your oncology patients at your primary practice setting/organization by insurance type?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 0-0",
        "rangeMin": 0,
        "rangeMax": 0,
        "allowedValues": [
          0
        ]
      }
    ]
  },
  {
    "questionId": "S0",
    "questionText": "S0: Are you or anyone in your immediate family affiliated in any way with any of the following on a full time or part time basis: the FDA, a pharmaceutical or biotech manufacturing company (other than for clinical trials), a market research, public relati",
    "items": [
      {
        "column": "S0",
        "label": "S0: Are you or anyone in your immediate family affiliated in any way with any of the following on a full time or part time basis: the FDA, a pharmaceutical or biotech manufacturing company (other than for clinical trials), a market research, public relati",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Yes"
          },
          {
            "value": 2,
            "label": "No"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S1",
    "questionText": "S1: In what state is your primary practice setting/organization located?",
    "items": [
      {
        "column": "S1",
        "label": "S1: In what state is your primary practice setting/organization located?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-51",
        "rangeMin": 1,
        "rangeMax": 51,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12,
          13,
          14,
          15,
          16,
          17,
          18,
          19,
          20,
          21,
          22,
          23,
          24,
          25,
          26,
          27,
          28,
          29,
          30,
          31,
          32,
          33,
          34,
          35,
          36,
          37,
          38,
          39,
          40,
          41,
          42,
          43,
          44,
          45,
          46,
          47,
          48,
          49,
          50,
          51
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Alabama"
          },
          {
            "value": 2,
            "label": "Alaska"
          },
          {
            "value": 3,
            "label": "Arizona"
          },
          {
            "value": 4,
            "label": "Arkansas"
          },
          {
            "value": 5,
            "label": "California"
          },
          {
            "value": 6,
            "label": "Colorado"
          },
          {
            "value": 7,
            "label": "Connecticut"
          },
          {
            "value": 8,
            "label": "Delaware"
          },
          {
            "value": 9,
            "label": "Florida"
          },
          {
            "value": 10,
            "label": "Georgia"
          },
          {
            "value": 11,
            "label": "Hawaii"
          },
          {
            "value": 12,
            "label": "Idaho"
          },
          {
            "value": 13,
            "label": "Illinois"
          },
          {
            "value": 14,
            "label": "Indiana"
          },
          {
            "value": 15,
            "label": "Iowa"
          },
          {
            "value": 16,
            "label": "Kansas"
          },
          {
            "value": 17,
            "label": "Kentucky"
          },
          {
            "value": 18,
            "label": "Louisiana"
          },
          {
            "value": 19,
            "label": "Maine"
          },
          {
            "value": 20,
            "label": "Maryland"
          },
          {
            "value": 21,
            "label": "Massachusetts"
          },
          {
            "value": 22,
            "label": "Michigan"
          },
          {
            "value": 23,
            "label": "Minnesota"
          },
          {
            "value": 24,
            "label": "Mississippi"
          },
          {
            "value": 25,
            "label": "Missouri"
          },
          {
            "value": 26,
            "label": "Montana"
          },
          {
            "value": 27,
            "label": "Nebraska"
          },
          {
            "value": 28,
            "label": "Nevada"
          },
          {
            "value": 29,
            "label": "New Hampshire"
          },
          {
            "value": 30,
            "label": "New Jersey"
          },
          {
            "value": 31,
            "label": "New Mexico"
          },
          {
            "value": 32,
            "label": "New York"
          },
          {
            "value": 33,
            "label": "North Carolina"
          },
          {
            "value": 34,
            "label": "North Dakota"
          },
          {
            "value": 35,
            "label": "Ohio"
          },
          {
            "value": 36,
            "label": "Oklahoma"
          },
          {
            "value": 37,
            "label": "Oregon"
          },
          {
            "value": 38,
            "label": "Pennsylvania"
          },
          {
            "value": 39,
            "label": "Rhode Island"
          },
          {
            "value": 40,
            "label": "South Carolina"
          },
          {
            "value": 41,
            "label": "South Dakota"
          },
          {
            "value": 42,
            "label": "Tennessee"
          },
          {
            "value": 43,
            "label": "Texas"
          },
          {
            "value": 44,
            "label": "Utah"
          },
          {
            "value": 45,
            "label": "Vermont"
          },
          {
            "value": 46,
            "label": "Virginia"
          },
          {
            "value": 47,
            "label": "Washington"
          },
          {
            "value": 48,
            "label": "Washington DC"
          },
          {
            "value": 49,
            "label": "West Virgina"
          },
          {
            "value": 50,
            "label": "Wisconsin"
          },
          {
            "value": 51,
            "label": "Wyoming"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Hid_Division",
    "questionText": "Hid_Division: Hidden question: to punch region",
    "items": [
      {
        "column": "Hid_Division",
        "label": "Hid_Division: Hidden question: to punch region",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-9",
        "rangeMin": 1,
        "rangeMax": 9,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "New England"
          },
          {
            "value": 2,
            "label": "Mid Atlantic"
          },
          {
            "value": 3,
            "label": "E North Central"
          },
          {
            "value": 4,
            "label": "W North Central"
          },
          {
            "value": 5,
            "label": "South Atlantic"
          },
          {
            "value": 6,
            "label": "E South Central"
          },
          {
            "value": 7,
            "label": "W South Central"
          },
          {
            "value": 8,
            "label": "Mountain"
          },
          {
            "value": 9,
            "label": "Pacific"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Hid_Region",
    "questionText": "Hid_Region: Hidden question: to punch region",
    "items": [
      {
        "column": "Hid_Region",
        "label": "Hid_Region: Hidden question: to punch region",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-4",
        "rangeMin": 1,
        "rangeMax": 4,
        "allowedValues": [
          1,
          2,
          3,
          4
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "North East"
          },
          {
            "value": 2,
            "label": "South"
          },
          {
            "value": 3,
            "label": "Midwest"
          },
          {
            "value": 4,
            "label": "West"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S1a",
    "questionText": "S1a: Which of the following best describes your primary practice setting/organization? Please check the description that best applies to the practice location at which you spend the greatest amount of time.",
    "items": [
      {
        "column": "S1a",
        "label": "S1a: Which of the following best describes your primary practice setting/organization? Please check the description that best applies to the practice location at which you spend the greatest amount of time.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Major academic medical center"
          },
          {
            "value": 2,
            "label": "Affiliated teaching hospital"
          },
          {
            "value": 3,
            "label": "Community hospital (not affiliated with an academic medical center)"
          },
          {
            "value": 4,
            "label": "Community hospital (affiliated with an academic medical center)"
          },
          {
            "value": 5,
            "label": "Multi-specialty private practice (group)"
          },
          {
            "value": 6,
            "label": "Single-specialty private practice (group)"
          },
          {
            "value": 7,
            "label": "Private practice (solo)"
          },
          {
            "value": 8,
            "label": "VA / Military hospital / DoD"
          },
          {
            "value": 9,
            "label": "Nursing homes"
          },
          {
            "value": 10,
            "label": "Other (please specify:)"
          }
        ]
      }
    ]
  },
  {
    "questionId": "hS1b",
    "questionText": "hS1b: Hidden question to punch Academic/Community",
    "items": [
      {
        "column": "hS1b",
        "label": "hS1b: Hidden question to punch Academic/Community",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Academic"
          },
          {
            "value": 2,
            "label": "Community"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S2",
    "questionText": "S2: Please select the title/role that best describes your current position within your practice/organization.",
    "items": [
      {
        "column": "S2",
        "label": "S2: Please select the title/role that best describes your current position within your practice/organization.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-12",
        "rangeMin": 1,
        "rangeMax": 12,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11,
          12
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Physician"
          },
          {
            "value": 2,
            "label": "Nurse"
          },
          {
            "value": 3,
            "label": "Nurse practitioner"
          },
          {
            "value": 4,
            "label": "Physician assistant"
          },
          {
            "value": 5,
            "label": "Medical assistant"
          },
          {
            "value": 6,
            "label": "Pharmacist"
          },
          {
            "value": 7,
            "label": "Practice administrator"
          },
          {
            "value": 8,
            "label": "Practice manager"
          },
          {
            "value": 9,
            "label": "Financial counselor or social worker"
          },
          {
            "value": 10,
            "label": "Reimbursement support role"
          },
          {
            "value": 11,
            "label": "Receptionist"
          },
          {
            "value": 12,
            "label": "Other (please specify:)"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Hid_Position",
    "questionText": "Hid_Position: Hidden question to punch Position",
    "items": [
      {
        "column": "Hid_Position",
        "label": "Hid_Position: Hidden question to punch Position",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "MD"
          },
          {
            "value": 2,
            "label": "PM (PRACTICE MANAGER)"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S3",
    "questionText": "S3: Which of the following best describes your primary medical specialty?",
    "items": [
      {
        "column": "S3",
        "label": "S3: Which of the following best describes your primary medical specialty?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-9",
        "rangeMin": 1,
        "rangeMax": 9,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Hematology"
          },
          {
            "value": 2,
            "label": "Hematology and Oncology"
          },
          {
            "value": 3,
            "label": "Radiation Oncology"
          },
          {
            "value": 4,
            "label": "Urology"
          },
          {
            "value": 5,
            "label": "Urological Oncology"
          },
          {
            "value": 6,
            "label": "Cardiology"
          },
          {
            "value": 7,
            "label": "Medical Oncology"
          },
          {
            "value": 8,
            "label": "Primary Care"
          },
          {
            "value": 9,
            "label": "Other (please specify:)"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S3a",
    "questionText": "S3a: Which specialty do you most closely identify yourself with?",
    "items": [
      {
        "column": "S3a",
        "label": "S3a: Which specialty do you most closely identify yourself with?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-2",
        "rangeMin": 1,
        "rangeMax": 2,
        "allowedValues": [
          1,
          2
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Oncologist"
          },
          {
            "value": 2,
            "label": "Urologist"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Hid_S3a",
    "questionText": "Hid_S3a: Hidden for S3a",
    "items": [
      {
        "column": "Hid_S3a",
        "label": "Hid_S3a: Hidden for S3a",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "HEM ONC"
          },
          {
            "value": 2,
            "label": "URO"
          },
          {
            "value": 3,
            "label": "MED ONC"
          }
        ]
      }
    ]
  },
  {
    "questionId": "S4",
    "questionText": "S4: Are you currently board-certified or board-eligible in your area of specialty?",
    "items": [
      {
        "column": "S4",
        "label": "S4: Are you currently board-certified or board-eligible in your area of specialty?",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Board-certified"
          },
          {
            "value": 2,
            "label": "Board-eligible"
          },
          {
            "value": 3,
            "label": "Neither"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Fin_Treater",
    "questionText": "Fin_Treater: Listfill for Final Treater",
    "items": [
      {
        "column": "Fin_Treater",
        "label": "Fin_Treater: Listfill for Final Treater",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "PC TREATER"
          },
          {
            "value": 2,
            "label": "AML TREATER"
          },
          {
            "value": 3,
            "label": "BLADDER CANCER TREATER"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Final_PM",
    "questionText": "Final_PM: Listfill for Final PM Category.",
    "items": [
      {
        "column": "Final_PM",
        "label": "Final_PM: Listfill for Final PM Category.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "PC TREATER PM"
          },
          {
            "value": 2,
            "label": "AML TREATER PM"
          },
          {
            "value": 3,
            "label": "BLADDER CANCER TREATER PM"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Secondary_Treater",
    "questionText": "Secondary_Treater: Listfill for Secondary Treater",
    "items": [
      {
        "column": "Secondary_Treater",
        "label": "Secondary_Treater: Listfill for Secondary Treater",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "PC TREATER"
          },
          {
            "value": 2,
            "label": "AML TREATER"
          },
          {
            "value": 3,
            "label": "BLADDER CANCER TREATER"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Secondary_PM",
    "questionText": "Secondary_PM: Listfill for Secondary PM",
    "items": [
      {
        "column": "Secondary_PM",
        "label": "Secondary_PM: Listfill for Secondary PM",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "PC TREATER PM"
          },
          {
            "value": 2,
            "label": "AML TREATER PM"
          },
          {
            "value": 3,
            "label": "BLADDER CANCER TREATER PM"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q4a",
    "questionText": "Q4a: And, of the attributes below, please indicate which ONE is most important to you when interacting with companies regarding their oncology drugs.",
    "items": [
      {
        "column": "Q4a",
        "label": "Q4a: And, of the attributes below, please indicate which ONE is most important to you when interacting with companies regarding their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-10",
        "rangeMin": 1,
        "rangeMax": 10,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Is a company I trust"
          },
          {
            "value": 2,
            "label": "Puts patients first"
          },
          {
            "value": 3,
            "label": "Enables timely and reliable access to medications"
          },
          {
            "value": 4,
            "label": "Provides a breadth of financial assistance options for patients"
          },
          {
            "value": 5,
            "label": "Invests in oncology clinical trials/pipeline"
          },
          {
            "value": 6,
            "label": "[pipe: Q4_row6]"
          },
          {
            "value": 7,
            "label": "Provides support services (non-financial) to patients and caregivers"
          },
          {
            "value": 8,
            "label": "Has a useful and easy-to-use website"
          },
          {
            "value": 9,
            "label": "Is focused on developing treatments for cancers with limited treatment options"
          },
          {
            "value": 10,
            "label": "Demonstrates corporate or social responsibility through community involvement/partnerships"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q5a",
    "questionText": "Q5a: And, of the attributes below, please indicate which ONE is most important to you when interacting with the people from a pharmaceutical company regarding their oncology drugs.",
    "items": [
      {
        "column": "Q5a",
        "label": "Q5a: And, of the attributes below, please indicate which ONE is most important to you when interacting with the people from a pharmaceutical company regarding their oncology drugs.",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-11",
        "rangeMin": 1,
        "rangeMax": 11,
        "allowedValues": [
          1,
          2,
          3,
          4,
          5,
          6,
          7,
          8,
          9,
          10,
          11
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "Have a presence in my practice / frequent touchpoints"
          },
          {
            "value": 2,
            "label": "Demonstrate in-depth knowledge of treatment area"
          },
          {
            "value": 3,
            "label": "Deliver quality product information and education"
          },
          {
            "value": 4,
            "label": "Understand my practice"
          },
          {
            "value": 5,
            "label": "Are responsive and dependable"
          },
          {
            "value": 6,
            "label": "Are collaborative"
          },
          {
            "value": 7,
            "label": "Are helpful in securing timely product access"
          },
          {
            "value": 8,
            "label": "Make my job easier by reducing hassles to prescribing"
          },
          {
            "value": 9,
            "label": "Give me confidence I am making the right treatment decisions"
          },
          {
            "value": 10,
            "label": "Are warm and friendly"
          },
          {
            "value": 11,
            "label": "Are adaptable to the current environment"
          }
        ]
      }
    ]
  },
  {
    "questionId": "Q10_12_PM",
    "questionText": "Q10_12_PM: Listfill for Secondary PM",
    "items": [
      {
        "column": "Q10_12_PM",
        "label": "Q10_12_PM: Listfill for Secondary PM",
        "context": "",
        "normalizedType": "categorical_select",
        "valueType": "Values: 1-3",
        "rangeMin": 1,
        "rangeMax": 3,
        "allowedValues": [
          1,
          2,
          3
        ],
        "scaleLabels": [
          {
            "value": 1,
            "label": "PC TREATER PM"
          },
          {
            "value": 2,
            "label": "AML TREATER PM"
          },
          {
            "value": 3,
            "label": "BLADDER CANCER TREATER PM"
          }
        ]
      }
    ]
  },
  {
    "questionId": "CE_Master_for_Programming_xlsx_NPINumber",
    "questionText": "CE_Master_for_Programming_xlsx_NPINumber: NPI Number",
    "items": [
      {
        "column": "CE_Master_for_Programming_xlsx_NPINumber",
        "label": "CE_Master_for_Programming_xlsx_NPINumber: NPI Number",
        "context": "",
        "normalizedType": "numeric_range",
        "valueType": "Values: 1023133550-1992918171",
        "rangeMin": 1023133550,
        "rangeMax": 1992918171
      }
    ]
  }
]